== Список литературы 

[arabic]
. [[l1]] Kraus V.B. The Genetics of Generalized Osteoarthritis (GOGO) study: study design and evaluation of osteoarthritis phenotypes / V.B. Kraus, J.M. Jordan, M. Doherty [et al.] // Osteoarthritis Cartilage. – 2007. – Vol. 15, №2. – P. 120–127.

. [[l2]] Nelson A.E. Differences in multijoint radiographic osteoarthritis phenotypes among African Americans and Caucasians: the Johnston County Osteoarthritis project / A.E. Nelson, J.B. Renner, T.A. Schwartz [et al.] // Arthritis Rheum. – 2011. – Vol. 63, №12. – P. 3843–3852.

. [[l3]] Nelson A.E. Brief report: differences in multijoint symptomatic osteoarthritis phenotypes by race and sex: the Johnston County Osteoarthritis Project / A.E. Nelson, Y.M. Golightly, J.B. Renner [et al.] // Arthritis Rheum. – 2013. – Vol. 65, №2. – P. 373–377.

. [[l4]] Nelson A.E. “Generalized Osteoarthritis”: A Systematic Review / A.E. Nelson, M.W. Smith, Y.M. Golightly, J.M. Jordan // Semin Arthritis Rheum. – 2013. – Vol. 43, №6. – Article ID 713.

. [[l5]] Moe R.H. Disease impact of hand OA compared with hip, knee and generalized disease in specialist rheumatology health care / R.H. Moe, M. Grotle, I. Kjeken [et al.] // Rheumatology (Oxford). – 2013. – Vol. 52, №1. – P. 189–196.

. [[l6]] Günther K.P. Prevalence of generalised osteoarthritis in patients with advanced hip and knee osteoarthritis: the Ulm Osteoarthritis Study / K.P. Günther, T. Stürmer, S. Sauerland [et al.] // Ann Rheum Dis. – 1998. – Vol. 57, №12. – P. 717–723.

. [[l7]] Min J.L. Association of the Frizzled-related protein gene with symptomatic osteoarthritis at multiple sites / J.L. Min, I. Meulenbelt, N. Riyazi [et al.] // Arthritis Rheum. – 2005. – Vol. 52, №4. – P. 1077–1080.

. [[l8]] Riyazi N. Risk factors in familial osteoarthritis: the GARP sibling study / N. Riyazi, F.R. Rosendaal, E. Slagboom [et al.] // Osteoarthritis Cartilage. – 2008. – Vol. 16, №6. – P. 654–659.

. [[l9]] Veronese N. Association of Osteoarthritis with Increased Risk of Cardiovascular Diseases in the Elderly: Findings from the Progetto Veneto Anziano Study Cohort / N. Veronese, C. Trevisan, M. De Rui [et al.] // Arthritis Rheumatol. – 2016. – Vol. 68, №5. – P. 1136–1144.

. [[l10]] Park J.H. Prevalence of symptomatic hip, knee, and spine osteoarthritis nationwide health survey analysis of an elderly Korean population / J.H. Park, J.Y. Hong, K. Han [et al.] // Medicine (Baltimore). – 2017. – Vol. 96, №12. – Article ID e6372.

. [[l11]] Rezuş E. From Pathogenesis to Therapy in Knee Osteoarthritis: Bench-to-Bedside / E. Rezuş, A. Burlui, A. Cardoneanu [et al.] // Int J Mol Sci. – 2021. – Vol. 22, №5. – Article ID 2697.

. [[l12]] Yao Q. Osteoarthritis: pathogenic signaling pathways and therapeutic targets / Q. Yao, X. Wu, C. Tao [et al.] // Signal Transduct Target Ther. – 2023. – Vol. 8, №1. – P. 1–31.

. [[l13]] Алексеева Л.И. Остеоартрит: эпидемиология, классификация, факторы риска и прогрессирования, клиника, диагностика, лечение / Л.И. Алексеева, Е.А. Таскина, Н.Г. Кашеварова // Современная ревматология. – 2019. – Т. 13, №2. – С. 9–21.

. [[l14]] Quicke J.G. Osteoarthritis year in review 2021: epidemiology & therapy / J.G. Quicke, P.G. Conaghan, N. Corp, G. Peat // Osteoarthritis Cartilage. – 2022. – Vol. 30, №2. – P. 196–206.

. [[l15]] Mukherjee A. The role of inflammatory mediators and matrix metalloproteinases (MMPs) in the progression of osteoarthritis / A. Mukherjee, B. Das // Biomater Biosyst. – 2024. – Vol. 13. – Article ID 100090.

. [[l16]] Molnar V. Cytokines and Chemokines Involved in Osteoarthritis Pathogenesis / V. Molnar, V. Matišić, I. Kodvanj [et al.] // Int J Mol Sci. – 2021. – Vol. 22, №17. – Article ID 9208.

. [[l17]] Nedunchezhiyan U. Obesity, Inflammation, and Immune System in Osteoarthritis / U. Nedunchezhiyan, I. Varughese, A.R.J. Sun [et al.] // Front Immunol. – 2022. – Vol. 13. – Article ID 907750.

. [[l18]] Szala D. The Role of MicroRNAs in the Pathophysiology of Osteoarthritis / D. Szala, M. Kopańska, J. Trojniak [et al.] // Int J Mol Sci. – 2024. – Vol. 25, №12. – Article ID 6352.

. [[l19]] Wu Y. The Therapeutic Potential and Role of miRNA, lncRNA, and circRNA in Osteoarthritis / Y. Wu, X. Lu, B. Shen, Y. Zeng // Curr Gene Ther. – 2019. – Vol. 19, №4. – P. 255–263.

. [[l20]] Zhou F. Subchondral Trabecular Microstructure and Articular Cartilage Damage Variations Between Osteoarthritis and Osteoporotic Osteoarthritis: A Cross-sectional Cohort Study / F. Zhou, L. Chu, X. Liu [et al.] // Front Med. – 2021. – Vol. 8. – Article ID 617200.

. [[l21]] Martel-Pelletier J. Magnetic resonance imaging assessments for knee segmentation and their use in combination with machine/deep learning as predictors of early osteoarthritis diagnosis and prognosis / J. Martel-Pelletier, P. Paiement, J.P. Pelletier // Ther Adv Musculoskelet Dis. – 2023. – Vol. 15. – Article ID 1759720X231165560.

. [[l22]] Zeng N. Infrapatellar Fat Pad and Knee Osteoarthritis / N. Zeng, Z.P. Yan, X.Y. Chen, G.X. Ni // Aging Dis. – 2020. – Vol. 11, №5. – P. 1317–1328.

. [[l23]] Steinmetz J.D. Global, regional, and national burden of osteoarthritis, 1990-2020 and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2021 / J.D. Steinmetz, G.T. Culbreth, L.M. Haile [et al.] // Lancet Rheumatol. – 2023. – Vol. 5, №9. – P. e508–e522.

. [[l24]] Балабанова Р.М. Динамика пятилетней заболеваемости болезнями костно-мышечной системы и их распространенности среди взрослого населения России за 2013–2017 гг. / Р.М. Балабанова, Т.В. Дубинина // Современная ревматология. – 2019. – Т. 13, №4. – С. 11–17.

. [[l25]] Галушко Е.А. Структура ревматических заболеваний среди взрослого населения России по данным эпидемиологического исследования (предварительные результаты) / Е.А. Галушко, Т.Ю. Большакова, И.Б. Виноградова [и др.] // Научно-практическая ревматология. – 2009. – Т. 47, №1. – С. 11–17.

. [[l26]] Kellgren J.H. Radiological assessment of osteo-arthrosis / J.H. Kellgren, J.S. Lawrence // Ann Rheum Dis. – 1957. – Vol. 16, №4. – P. 494–502.

. [[l27]] Zhang W. EULAR evidence-based recommendations for the diagnosis of knee osteoarthritis / W. Zhang, M. Doherty, G. Peat [et al.] // Ann Rheum Dis. – 2010. – Vol. 69, №3. – P. 483–489.

. [[l28]] Zhang W. EULAR evidence-based recommendations for the diagnosis of hand osteoarthritis: report of a task force of ESCISIT / W. Zhang, M. Doherty, B.F. Leeb [et al.] // Ann Rheum Dis. – 2009. – Vol. 68, №1. – P. 8–17.

. [[l29]] Munteanu S.E. Characterisation of first metatarsophalangeal joint osteoarthritis using magnetic resonance imaging / S.E. Munteanu, M. Auhl, J.M. Tan [et al.] // Clin Rheumatol. – 2021. – Vol. 40, №12. – P. 5067–5076.

. [[l30]] Alkhalifah K.M. A Systematic Review and Meta-Analysis of the Prevalence of Hallux Valgus in the General Population / K.M. Alkhalifah, M.M. Almotiri, A.E. Alharbi [et al.] // Cureus. – 2023. – Vol. 15, №7. – Article ID e42739.

. [[l31]] Du R. Facet Joint Syndrome: Pathophysiology, Diagnosis, and Treatment / R. Du, G. Xu, X. Bai, Z. Li // J Pain Res. – 2022. – Vol. 15. – P. 3689–3710.

. [[l32]] Altman R. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee / R. Altman, E. Asch, D. Bloch [et al.] // Arthritis Rheum. – 1986. – Vol. 29, №8. – P. 1039–1049.

. [[l33]] Altman R. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip / R. Altman, G. Alarcón, D. Appelrouth [et al.] // Arthritis Rheum. – 1991. – Vol. 34, №5. – P. 505–514.

. [[l34]] Altman R. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hand / R. Altman, G. Alarcón, D. Appelrouth [et al.] // Arthritis Rheum. – 1990. – Vol. 33, №11. – P. 1601–1610.

. [[l35]] Zammit G.V. Development of a diagnostic rule for identifying radiographic osteoarthritis in people with first metatarsophalangeal joint pain / G.V. Zammit, S.E. Munteanu, H.B. Menz // Osteoarthritis Cartilage. – 2011. – Vol. 19, №8. – P. 939–945.

. [[l36]] Arnold J.B. International Foot and Ankle Osteoarthritis Consortium review and research agenda for diagnosis, epidemiology, burden, outcome assessment and treatment / J.B. Arnold, C.J. Bowen, L.S. Chapman [et al.] // Osteoarthritis Cartilage. – 2022. – Vol. 30, №7. – P. 945–955.

. [[l37]] Abramoff B. Osteoarthritis: Pathology, Diagnosis, and Treatment Options / B. Abramoff, F.E. Caldera // Med Clin North Am. – 2020. – Vol. 104, №2. – P. 293–311.

. [[l38]] Collins J.E. Trajectories and risk profiles of pain in persons with radiographic, symptomatic knee osteoarthritis: data from the osteoarthritis initiative / J.E. Collins, J.N. Katz, E.E. Dervan, E. Losina // Osteoarthritis Cartilage. – 2014. – Vol. 22, №5. – P. 622–630.

. [[l39]] Katz J.N. Diagnosis and Treatment of Hip and Knee Osteoarthritis: A Review / J.N. Katz, K.R. Arant, R.F. Loeser // JAMA. – 2021. – Vol. 325, №6. – P. 568–578.

. [[l40]] Tuncay Duruöz M. Clinical aspects and outcomes in osteoarthritis / M. Tuncay Duruöz, N. Öz, D.E. Gürsoy, H. Hande Gezer // Best Pract Res Clin Rheumatol. – 2023. – Vol. 37, №2. – Article ID 101855.

. [[l41]] Abhishek A. Diagnosis and clinical presentation of osteoarthritis / A. Abhishek, M. Doherty // Rheum Dis Clin North Am. – 2013. – Vol. 39, №1. – P. 45–66.

. [[l42]] Parsons C. Concordance between clinical and radiographic evaluations of knee osteoarthritis / C. Parsons, N.R. Fuggle, M.H. Edwards [et al.] // Aging Clin Exp Res. – 2018. – Vol. 30, №1. – P. 17–25.

. [[l43]] Nelson A.E. Osteoarthritis year in review 2017: clinical / A.E. Nelson // Osteoarthritis Cartilage. – 2018. – Vol. 26, №3. – P. 319–325.

. [[l44]] Altman R.D. Osteoarthritis in the Elderly Population / R.D. Altman // In: Nakasato Y., Yung R. (eds) Geriatric Rheumatology. – New York, NY: Springer, 2011. – P. 187–196.

. [[l45]] Bijlsma J.W.J. Osteoarthritis: An update with relevance for clinical practice / J.W.J. Bijlsma, F. Berenbaum, F.P.J.G. Lafeber // Lancet. – 2011. – Vol. 377, №9783. – P. 2115–2126.

. [[l46]] Myers S.L. Osteoarthritis and crystal-associated synovitis / S.L. Myers // Atlas of Osteoarthritis. – 4th ed. – Philadelphia: PCML, 2005. – P. 54–81.

. [[l47]] Engh G.A. The difficult knee: severe varus and valgus / G.A. Engh // Clin Orthop Relat Res. – 2003. – Vol. 416. – P. 58–63.

. [[l48]] Каратеев А.Е. Остеоартрит суставов позвоночника как причина хронической боли в нижней части спины / А.Е. Каратеев, О.С. Давыдов, Н.Н. Яхно [и др.] // Научнопрактическая ревматология. – 2019. – Т. 57, №0. – С. 1–16.

. [[l49]] Ассоциация травматологов-ортопедов России. Вальгусное отклонение первого пальца стопы: клинические рекомендации [Электронный ресурс]. – 2016. – URL: https://cr.minzdrav.gov.ru/preview-cr/778_1 (дата обращения: 05.03.2025).

. [[l50]] Ассоциация ревматологов России, Ассоциация травматологов-ортопедов России, Общероссийская общественная организация Ассоциация реабилитологов России. Гонартроз: клинические рекомендации [Электронный ресурс]. – 2024. – URL: https://cr.minzdrav.gov.ru/view-cr/868_1 (дата обращения: 05.03.2025).

. [[l51]] Ассоциация ревматологов России, Ассоциация травматологов-ортопедов России, Общероссийская общественная организация Ассоциация реабилитологов России. Коксартроз: клинические рекомендации [Электронный ресурс]. – 2024. – URL: https://cr.minzdrav.gov.ru/view-cr/870_1 (дата обращения: 05.03.2025).

. [[l52]] Межрегиональная общественная организация «Общество по изучению боли». Скелетно-мышечные (неспецифические) боли в нижней части спины: клинические рекомендации [Электронный ресурс]. – 2023. – URL: https://cr.minzdrav.gov.ru/preview-cr/778_1 (дата обращения: 05.03.2025).

. [[l53]] Boxer M.C. Osteoarthritis involving the metatarsophalangeal joints and management of metatarsophalangeal joint pain via injection therapy / M.C. Boxer // Clin Podiatr Med Surg. – 1994. – Vol. 11, №1. – P. 125–132.

. [[l54]] Menz H.B. Comparative Responsiveness of Outcome Measures for the Assessment of Pain and Function in Osteoarthritis of the First Metatarsophalangeal Joint / H.B. Menz, M. Auhl, J.M. Tan [et al.] // Arthritis Care Res (Hoboken). – 2020. – Vol. 72, №5. – P. 679–684.

. [[l55]] Kamps A. Comorbidity in incident osteoarthritis cases and matched controls using electronic health record data / A. Kamps, J. Runhaar, M.A.J. de Ridder [et al.] // Arthritis Res Ther. – 2023. – Vol. 25, №1. – Article ID S13075-023-03086-8.

. [[l56]] Мазуров В.И. Мультиморбидность при остеоартрите и плейотропные эффекты симптоматических средств замедленного действия. Резолюция международного мультидисциплинарного совета экспертов / В.И. Мазуров, А.М. Лила, Л.И. Алексеева [и др.] // Современная ревматология. – 2023. – Т. 17, №5. – С. 123–131.

. [[l57]] Veronese N. Association of Osteoarthritis With Increased Risk of Cardiovascular Diseases in the Elderly: Findings From the Progetto Veneto Anziano Study Cohort / N. Veronese, C. Trevisan, M. De Rui [et al.] // Arthritis Rheumatol. – 2016. – Vol. 68, №5. – P. 1136–1144.

. [[l58]] Таскина Е.А. Клинико-инструментальная характеристика остеоартрита при гиперурикемии / Е.А. Таскина, А.М. Лила, Л.И. Алексеева [и др.] // Современная ревматология. – 2024. – Т. 18, №5. – С. 81–89.

. [[l59]] Таскина Е.А. Взаимосвязь гиперхолестеринемии и остеоартрита (предварительные результаты) / Е.А. Таскина, Л.И. Алексеева, Н.Г. Кашеварова [и др.] // Терапевтический архив. – 2024. – Т. 96, №5. – С. 471–478.

. [[l60]] Лила А.М. Клинические рекомендации (проект) по диагностике и лечению первичного остеоартрита для специалистов первичного звена (врачей-терапевтов, врачей общей практики) / А.М. Лила, Л.И. Алексеева, Е.А. Таскина [и др.] // Терапия. – 2023. – Т. 9, №1(63). – С. 7–22.

. [[l61]] Babaei M. Correlation between systemic markers of inflammation and local synovitis in knee osteoarthritis / M. Babaei, Y. Javadian, H. Narimani [et al.] // Caspian J Intern Med. – 2019. – Vol. 10, №4. – P. 383.

. [[l62]] Heidari B. Knee osteoarthritis diagnosis, treatment and associated factors of progression: part II / B. Heidari // Caspian J Intern Med. – 2011. – Vol. 2, №3. – P. 249–255.

. [[l63]] Foster Z.J. Polyarticular Joint Pain in Adults: Evaluation and Differential Diagnosis / Z.J. Foster, A.L. Day, J.Miller // Am Fam Physician. – 2023. – Vol. 107, №1. – P. 42–51.

. [[l64]] Esmonde-White K.O.A. Raman Spectroscopy of Synovial Fluid as a Tool for Diagnosing Osteoarthritis / K.O.A. Esmonde-White, G.S. Mandair, F. Raaii [et al.] // J Biomed Opt. – 2009. – Vol. 14, №3. – Article ID 034013.

. [[l65]] Kim S. Metabolite profiles of synovial fluid change with the radiographic severity of knee osteoarthritis / S. Kim, J. Hwang, J. Kim [et al.] // Joint Bone Spine. – 2017. – Vol. 84, №5. – P. 605–610.

. [[l66]] Mickiewicz B. Metabolic analysis of knee synovial fluid as a potential diagnostic approach for osteoarthritis / B. Mickiewicz, J.J. Kelly, T.E. Ludwig [et al.] // J Orthop Res. – 2015. – Vol. 33, №11. – P. 1631–1638.

. [[l67]] Jokic A. Laboratory testing of extravascular body fluids: National recommendations on behalf of the Croatian Society of Medical Biochemistry and Laboratory Medicine. Part II - Synovial fluid / A. Jokic, L.M. Kopcinovic, J. Culej [et al.] // Biochem Med (Zagreb). – 2020. – Vol. 30, №3. – P. 1–14.

. [[l68]] Martel-Pelletier J. A new decision tree for diagnosis of osteoarthritis in primary care: international consensus of experts / J. Martel-Pelletier, E. Maheu, J. P. Pelletier [et al.] // Aging Clin Exp Res. – 2019. – Vol. 31, №1. – P. 19–30.

. [[l69]] А.В. Смирнов. Атлас рентгенологической диагностики первичного остеоартроза. – М.: ИМА-ПРЕСС, 2010. — 40 с.

. [[l70]] Arden N. Atlas of Osteoarthritis. Second edition / N. Arden, F.J. Blanco, O. Bruyère [et al.]. – London: Springer Healthcare Ltd., 2018. – 90 с.

. [[l71]] Michael J.W.P. The epidemiology, etiology, diagnosis, and treatment of osteoarthritis of the knee / J.W.P. Michael, K.U. Schlüter-Brust, P. Eysel // Dtsch Arztebl Int. – 2010. – Vol. 107, №9. – P. 152–162.

. [[l72]] Dieppe P. Osteoarthritis. A. Clinical features / P. Dieppe // Primer on the Rheumatic Diseases. – 13th Edition. – Ed. J.H. Klippel [et al.]. – 2008. – P. 224–228.

. [[l73]] Weber M.A. Modern Radiological Imaging of Osteoarthritis of The Hip Joint With Consideration of Predisposing Conditions / M.A. Weber, C. Merle, C. Rehnitz [et al.] // RoFo. – 2016. – Vol. 188, №7. – P. 635–651.

. [[l74]] Смирнов А.В. Рентгенологическая диагностика изменений в тазобедренном суставе при ревматических заболеваниях / А.В. Смирнов // Consilium Medicum. – 2003. – Т. 5, №8. – С. 442–446.

. [[l75]] Haugen I.K. 2023 EULAR classification criteria for hand osteoarthritis / I.K. Haugen, D.T. Felson, A. Abhishek [et al.] // Ann Rheum Dis. – 2024. – Vol. 83, №11. – P. 1428–1435.

. [[l76]] Кудинский Д.М. Комплексная клинико-лучевая диагностика эрозивного остеоартрита кистей: дис. канд. мед. наук: 3.1.27 – Ревматология, 3.1.25 – Лучевая диагностика / Д.М. Кудинский; ФГБНУ "Научно-исследовательский институт ревматологии имени В.А. Насоновой". – Москва, 2023. – 109 с.

. [[l77]] Балабанова Р.М. Остеоартрит суставов кисти: диагностика, патогенез, лечение / Р.М. Балабанова, С.А. Кудинский, Д.А. Лесников [и др.] // Современная ревматология. – 2018. – Т. 12, №1. – С. 73–77.

. [[l78]] Кудинский Д.М. Рентгенографическая диагностика эрозивного остеоартрита суставов кистей / Д.М. Кудинский, А.В. Смирнов, Л.И. Алексеева [и др.] // Научно-практическая ревматология. – 2019. – Т. 57, №6. – С. 662–667.

. [[l79]] Bowen C. Natural History of Radiographic First Metatarsophalangeal Joint Osteoarthritis: A Nineteen-Year Population-Based Cohort Study / C. Bowen, L. Gates, P. McQueen [et al.] // Arthritis Care Res (Hoboken). – 2020. – Vol. 72, №9. – P. 1224–1230.

. [[l80]] Карданов А.А. Оперативное лечение деформаций и заболеваний костей и суставов первого луча стопы: дис. ... д-ра мед. наук: 14.00.22 – Травматология и ортопедия / А.А. Карданов; Российский университет дружбы народов. – Москва, 2009. – 222 с.

. [[l81]] Маркс В.О. Ортопедическая диагностика / В.О. Маркс (ред.) // Ортопедическая диагностика. – 1978. – С. 396–400.

. [[l82]] Koes B.W. An updated overview of clinical guidelines for the management of non-specific low back pain in primary care / B.W. Koes, M. Van Tulder, C.W.C. Lin [et al.] // Eur Spine J. – 2010. – Vol. 19, №12. – P. 2075–2094.

. [[l83]] Oliveira C.B. Clinical practice guidelines for the management of non-specific low back pain in primary care: an updated overview / C.B. Oliveira, C.G. Maher, R.Z. Pinto [et al.] // Eur Spine J. – 2018. – Vol. 27, №11. – P. 2791–2803.

. [[l84]] Кудинский Д.М. Сравнение рентгенографии и магнитно-резонансной томографии при диагностике остеоартрита суставов кистей / Д.М. Кудинский, А.В. Смирнов, Л.И. Алексеева [и др.] // Научно-практическая ревматология. – 2019. – Т. 57, №1. – С. 91–99.

. [[l85]] Кудинский Д.М. Дегенеративные и воспалительные изменения в суставах кистей при остеоартрите по данным магнитно-резонансной томографии / Д.М. Кудинский, С.А. Алексеев, Л.И. Алексеева [и др.] // Научно-практическая ревматология. – 2020. – Т. 58, №1. – С. 15–21.

. [[l86]] Roemer F.W. Imaging in Osteoarthritis / F.W. Roemer, A. Guermazi, S. Demehri, W. Wirth, R. Kijowski // Osteoarthritis Cartilage. – 2022. – Vol. 30, №7. – P. 913–934.

. [[l87]] Sukerkar P.A. Imaging of Osteoarthritis of the Knee / P.A. Sukerkar, Z. Doyle // Radiol. Clin. North Am. – 2022. – Vol. 60, №4. – P. 605–616.

. [[l88]] Kim J.S. FDA/Arthritis Foundation osteoarthritis drug development workshop recap: Assessment of long-term benefit / J.S. Kim, S. Borges, D.J. Clauw [et al.] // Semin. Arthritis Rheum. – 2022. – Vol. 56. – Article ID152070.

. [[l89]] Dell’Isola A. Identification of clinical phenotypes in knee osteoarthritis: a systematic review of the literature / A. Dell’Isola, R. Allan, S. L. Smith [et al.] // BMC Musculoskelet. Disord. – 2016. – Vol. 17, №1. – P. 1–12.

. [[l90]] Mobasheri A. Recent advances in understanding the phenotypes of osteoarthritis / A. Mobasheri, S. Saarakkala, M. Finnilä [et al.] // F1000Res. – 2019. – Vol. 8.

. [[l91]] Лила А.М. Современные подходы к фенотипированию остеоартрита / А.М. Лила, Л.И. Алексеева, К.А. Телышев // Современная ревматология. – 2019. – Т. 13, №2. – С. 4–8.

. [[l92]] Nelson F.R.T. The Value of Phenotypes in Knee Osteoarthritis Research / F.R.T. Nelson // Open Orthop. J. – 2018. – Vol. 12, №1. – P. 105–114.

. [[l93]] Dell’Isola A. Classification of patients with knee osteoarthritis in clinical phenotypes: Data from the osteoarthritis initiative / A. Dell’Isola, M. Steultjens // PLoS One. – 2018. – Vol. 13, №1. – Article ID 0191045.

. [[l94]] Berenbaum F. Deep phenotyping of osteoarthritis: a step forward / F. Berenbaum // Ann. Rheum. Dis. – 2018. – Vol. 78, №1. – P. 3–5.

. [[l95]] Martel-Pelletier J. Osteoarthritis / J. Martel-Pelletier, A.J. Barr, F.M. Cicuttini [et al.] // Nat. Rev. Dis. Primers. – 2016. – Vol. 2.

. [[l96]] National Institute for Health and Care Excellence (NICE). Osteoarthritis in over 16s: diagnosis and management: клинические рекомендации [Электронный ресурс]. – NICE Guideline, No. 226. – London: NICE, 2022. – ISBN-13: 978-1-4731-4740-9. – URL: https://www.ncbi.nlm.nih.gov/books/NBK588843/ (дата обращения: 05.03.2025).

. [[l97]] Rivero-Santana A. Treatment Preferences in Patients with Knee or Hip Osteoarthritis: An Overview / A. Rivero-Santana, L. Perestelo-Perez, J. Perez-Ramos [et al.] // In: Osteoarthritis - Diagnosis, Treatment and Surgery / Ed. by InTech. – InTech, 2012.

. [[l98]] Kolasinski S.L. 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee / S.L. Kolasinski, T. Neogi, M.C. Hochberg [et al.] // Arthritis Rheumatol. – 2020. – Vol. 72, №2. – P. 220–233.

. [[l99]] Brophy R.H. AAOS Clinical Practice Guideline Summary: Management of Osteoarthritis of the Knee (Nonarthroplasty), Third Edition / R.H. Brophy, Y.A. Fillingham // J. Am. Acad. Orthop. Surg. – 2022. – Vol. 30, №9. – P. E721–E729.

. [[l100]] Bruyère O. An updated algorithm recommendation for the management of knee osteoarthritis from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) / O. Bruyère, G. Honvo, N. Veronese [et al.] // Semin. Arthritis Rheum. – 2019. – Vol. 49, №3. – P. 337–350.

. [[l101]] Bannuru R.R. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis / R.R. Bannuru, M.C. Osani, E.E. Vaysbrot [et al.] // Osteoarthritis Cartilage. – 2019. – Vol. 27, №11. – P. 1578–1589.

. [[l102]] National Institute for Health and Care Excellence (NICE). Osteoarthritis: care and management [Электронный ресурс]. – NICE Clinical Guidelines, No. 177. – London: NICE, 2020. – ISBN-13: 978-1-4731-0426-6. – URL: https://www.ncbi.nlm.nih.gov/books/NBK568417/ (дата обращения: 05.03.2025).

. [[l103]] Sawitzke A.D. Personalized medicine for osteoarthritis: where are we now? / A.D. Sawitzke // Ther. Adv. Musculoskelet. Dis. – 2013. – Vol. 5, №2. – P. 67-75.

. [[l104]] Lambova S.N. Osteoarthritis - From New Insights into Disease Pathogenesis to Contemporary Personalized Therapeutic Strategy / S.N. Lambova // Curr. Rheumatol. Rev. – 2021. – Vol. 17, №1. – P. 4–6.

. [[l105]] Karsdal M.A. Osteoarthritis - a case for personalized health care? / M.A. Karsdal, C. Christiansen, C. Ladel [et al.] // Osteoarthritis Cartilage. – 2014. – Vol. 22, №1. – P. 7–16.

. [[l106]] Darlow B. Making sense of osteoarthritis: A narrative review / B. Darlow, J. Belton, M. Brown [et al.] // Osteoarthritis Cartilage. – 2025. – Vol. 33, №1. – P. 17–26.

. [[l107]] Veronese N. Multimodal Multidisciplinary Management of Patients with Moderate to Severe Pain in Knee Osteoarthritis: A Need to Meet Patient Expectations / N. Veronese, C. Cooper, O. Bruyère [et al.] // Drugs. – 2022. – Vol. 82, №13. – P. 1347.

. [[l108]] Таскина E.A. Длительное многоцентровое наблюдательное исследование препарата Алфлутоп в России: применение у пациентов с остеоартритом коленных суставов (сообщение 4) / Е.А. Таскина, Л.И. Алексеева, Н.Г. Кашеварова, А.М. Лила [и др.] // Современная ревматология. – 2024. – Т. 18, №4. – С. 80–88.

. [[l109]] Yang W. The Efficacy and Safety of Disease-Modifying Osteoarthritis Drugs for Knee and Hip Osteoarthritis-a Systematic Review and Network Meta-Analysis / W. Yang, C. Sun, S.Q. He [et al.] // J. Gen. Intern. Med. – 2021. – Vol. 36, №7. – P. 2085–2093.

. [[l110]] Veronese N. Glucosamine sulphate: an umbrella review of health outcomes / N. Veronese, J. Demurtas, L. Smith [et al.] // Ther. Adv. Musculoskelet. Dis. – 2020. – Vol. 12. – Article ID 20975927.

. [[l111]] Singh J.A. Chondroitin for osteoarthritis / J.A. Singh, S. Noorbaloochi, R. Macdonald, L.J. Maxwell [et al.] // Cochrane Database Syst. Rev. – 2015. – Vol. 1, №1. – Article ID CD005614.

. [[l112]] Simental-Mendía M. Effect of glucosamine and chondroitin sulfate in symptomatic knee osteoarthritis: a systematic review and meta-analysis of randomized placebo-controlled trials / M. Simental-Mendía, A. Sánchez-García, F. Vilchez-Cavazos [et al.] // Rheumatol. Int. – 2018. – Vol. 38, №8. – P. 1413–1428.

. [[l113]] Hochberg M.C. Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxib / M.C. Hochberg, J. Martel-Pelletier, J. Monfort [et al.] // Ann. Rheum. Dis. – 2016. – Vol. 75, №1. – P. 37–44.

. [[l114]] Honvo G. Efficacy of Chondroitin Sulfate in Patients with Knee Osteoarthritis: A Comprehensive Meta-Analysis Exploring Inconsistencies in Randomized, Placebo-Controlled Trials / G. Honvo, O. Bruyère, A. Geerinck [et al.] // Adv. Ther. – 2019. – Vol. 36, №5. – P. 1085– 1099.

. [[l115]] Lila A.M. Chondroitin sulfate and glucosamine combination in patients with knee and hip osteoarthritis: A long-term observational study in Russia / A.M. Lila, L.I. Alekseeva, A.A. Baranov [et al.] // World J. Orthop. – 2023. – Vol. 14, №6. – P. 443–457.

. [[l116]] Каратеев А.Е. Биоактивный концентрат мелкой морской рыбы: оценка эффективности и безопасности препарата на основании анализа 37 клинических исследований / А.Е. Каратеев // Современная ревматология. – 2020. – Т. 14, №4. – С. 111–124.

. [[l117]] Simental-Mendía M. Efficacy and safety of avocado-soybean unsaponifiables for the treatment of hip and knee osteoarthritis: A systematic review and meta-analysis of randomized placebo-controlled trials / M. Simental-Mendía, A. Sánchez-García, C.A. Acosta-Olivo [et al.] // Int. J. Rheum. Dis. – 2019. – Vol. 22, №9. – P. 1607–1615.

. [[l118]] Каратеев А.Е. Терапевтический потенциал лекарственного препарата на основе неомыляемых соединений авокадо и сои при лечении остеоартрита: данные российских и международных исследований (описательный обзор) / А.Е. Каратеев, Л.А. Алексеева [и др.] // Современная ревматология. – 2022. – Т. 16, №2. – С. 48–55.

. [[l119]] Торшин И.Ю. Метаанализ клинических исследований эффективности лечения остеоартрита препаратом Хондрогард / И.Ю. Торшин, А.М. Лила, А.В. Наумов [и др.] // ФАРМАКОЭКОНОМИКА. Современная фармакоэкономика и фармакоэпидемиология. – 2021. – Т. 13, №4. – С. 388–399.

. [[l120]] Tenti S. Prescription-grade crystalline glucosamine sulfate as an add-on therapy to conventional treatments in erosive osteoarthritis of the hand: results from a 6-month observational retrospective study / S. Tenti, N. Veronese, S. Cheleschi [et al.] // Aging Clin. Exp. Res. – 2022. – Vol. 34, №7. – P. 1613-1625.

. [[l121]] Verbruggen G. Chondroitin sulfate: S/DMOAD (structure/disease modifying anti-osteoarthritis drug) in the treatment of finger joint OA / G. Verbruggen, S. Goemaere, E.M. Veys [et al.] // Osteoarthritis Cartilage. – 1998. – Vol. 6, Suppl. A. – P. 37–38.

. [[l122]] Лила А.М. Обновленные рекомендации по ведению пациентов с остеоартритом суставов кистей / А.М. Лила, Л.И. Алексеева, Е.А. Таскина, Н.Г. Кашеварова [и др.] // РМЖ. – 2020. – Т. 7. – С. 2–8.

. [[l123]] Алексеева Л.И. Новые подходы к лечению неспецифической боли в нижней части спины / Л.И. Алексеева, А.В. Баранов, А. [и др.] // Научно-практическая ревматология. – 2016. – Т. 54, №1. – С. 16–20.

. [[l124]] Lambert C. Composition Analysis and Pharmacological Activity of Avocado/Soybean Unsaponifiable Products Used in the Treatment of Osteoarthritis / C. Lambert, G. Bellemère, G. Boyer [et al.] // Front. Pharmacol. – 2022. – Vol. 12. – Article ID 781389.

. [[l125]] Stellavato A. Comparative Analyses of Pharmaceuticals or Food Supplements Containing Chondroitin Sulfate: Are Their Bioactivities Equivalent? / A. Stellavato, O.F. Restaino, V. Vassallo [et al.] // Adv. Ther. – 2019. – Vol. 36, №11. – P. 3221–3237.

. [[l126]] Reginster J.Y. Highly purified chondroitin sulfate: a literature review on clinical efficacy and pharmacoeconomic aspects in osteoarthritis treatment / J.Y. Reginster, N. Veronese [et al.] // Aging Clin. Exp. Res. – 2021. – Vol. 33, №1. – P. 37–47.

. [[l127]] Gabay C. Symptomatic effects of chondroitin 4 and chondroitin 6 sulfate on hand osteoarthritis: a randomized, double-blind, placebo-controlled clinical trial at a single center / C. Gabay, C. Medinger-Sadowski, D. Gascon [et al.] // Arthritis Rheum. – 2011. – Vol. 63, №11. – P. 3383–3391.

. [[l128]] Zhu X. Effectiveness and safety of glucosamine and chondroitin for the treatment of osteoarthritis: a meta-analysis of randomized controlled trials / X. Zhu, L. Sang, D. Wu [et al.] // J. Orthop. Surg. Res. – 2018. – Vol. 13, №1. – Article ID 0871-5.

. [[l129]] Meng Z. Efficacy and safety of the combination of glucosamine and chondroitin for knee osteoarthritis: a systematic review and meta-analysis / Z. Meng, J. Liu, N. Zhou [et al.] // Arch. Orthop. Trauma Surg. – 2023. – Vol. 143, №1. – P. 409–421.

. [[l130]] Лила А.М. Терафлекс в комплексной терапии остеоартроза коленных суставов и остеохондроза позвоночника (результаты клинического исследования) / А.М. Лила, В.И. Мазуров, О.В. Шидловская, М.С. Шостак [и др.] // РМЖ. – 2005. – №24. – С. 1618.

. [[l131]] Лила А.М. Эффективность лечения остеоартрита коленного и тазобедренного суставов комбинированным препаратом хондроитина сульфата и глюкозамина гидрохлорида: промежуточные результаты российского наблюдательного исследования / А.М. Лила, Л.И. Алексеева, К.А. Телышев [и др.] // Современная ревматология. – 2020. – Т. 14, №3. – С. 71–78.

. [[l132]] Kloppenburg M. 2018 update of the EULAR recommendations for the management of hand osteoarthritis / M. Kloppenburg, F.P.B. Kroon, F.J. Blanco [et al.] // Ann. Rheum. Dis. – 2019. – Vol. 78, №1. – P. 16–24.

. [[l133]] Bruyere O. Total joint replacement after glucosamine sulphate treatment in knee osteoarthritis: results of a mean 8-year observation of patients from two previous 3-year, randomised, placebo-controlled trials / O. Bruyere, K. Pavelka, L.C. Rovati [et al.] // Osteoarthritis Cartilage. – 2008. – Vol. 16, №2. – P. 254–260.

. [[l134]] Raynauld J.P. Total Knee Replacement as a Knee Osteoarthritis Outcome: Predictors Derived from a 4-Year Long-Term Observation following a Randomized Clinical Trial Using Chondroitin Sulfate / J.P. Raynauld, J. Martel-Pelletier, M. Dorais [et al.] // Cartilage. – 2013. – Vol. 4, №3. – P. 219–226.

. [[l135]] Prieto-Alhambra D. Trends of use of different SYSADOA in patients with osteoarthritis: a population-based cohort study / D. Prieto-Alhambra, M. Herrero, J. Vergés [et al.] // Osteoarthritis Cartilage. – 2013. – Vol. 21. – P. S164–S165.

. [[l136]] Ma H. Glucosamine Use, Inflammation, and Genetic Susceptibility, and Incidence of Type 2 Diabetes: A Prospective Study in UK Biobank / H. Ma, X. Li, T. Zhou [et al.] // Diabetes Care. – 2020. – Vol. 43, №4. – P. 719–725.

. [[l137]] Ma H. Association of habitual glucosamine use with risk of cardiovascular disease: prospective study in UK Biobank / H. Ma, X. Li, D. Sun [et al.] // BMJ. – 2019. – Vol. 365. – Article ID L1628.

. [[l138]] Mazzucchelli R. Risk of acute myocardial infarction among new users of chondroitin sulfate: A nested case-control study / R. Mazzucchelli, S. Rodríguez-Martín, A. García-Vadillo [et al.] // PLoS One. – 2021. – Vol. 16, №7. – Article ID 0253932.

. [[l139]] Лила А.М. Симптоматические препараты замедленного действия (SYSADOA): новые возможности применения / А.М. Лила, Е.А. Таскина, Л.И. Алексеева, Н.Г. Кашеварова [и др.] // Современная ревматология. – 2022. – Т. 16, №2. – С. 99–106.

. [[l140]] Алексеева Л.И. Сравнительное исследование эффективности и безопасности препарата Хондрогард® при комбинированном (внутрисуставное и внутримышечное) и внутримышечном введении у пациентов с остеоартритом коленных суставов / Л.И. Алексеева, Е.П. Шарапова, Н.Г. Кашеварова [и др.] // Современная ревматология. – 2018. – Т. 12, №2. – С. 44–49.

. [[l141]] Blotman F. Efficacy and safety of avocado/soybean unsaponifiables in the treatment of symptomatic osteoarthritis of the knee and hip. A prospective, multicenter, three-month, randomized, double-blind, placebo-controlled trial / F. Blotman, M.E. Maheu [et al.] // Rev. Rhum. Engl. Ed. – 1997. – Vol. 64, №12. – P. 825–834.

. [[l142]] Appelboom T. Symptoms modifying effect of avocado/soybean unsaponifiables (ASU) in knee osteoarthritis. A double blind, prospective, placebo-controlled study / T. Appelboom, J. Schuermans, G. Verbruggen [et al.] // Scand. J. Rheumatol. – 2001. – Vol. 30, №4. – P. 242–247.

. [[l143]] Głuszko P. Symptom-modifying effects of oral avocado/soybean unsaponifiables in routine treatment of knee osteoarthritis in Poland. An open, prospective observational study of patients adherent to a 6-month treatment / P. Głuszko, M. Stasiek [et al.] // Reumatologia. – 2016. – Vol. 54, №5. – P. 217-226.

. [[l144]] Шостак Н.А. Дегенеративное поражение позвоночника: представления о болезни, подходы к терапии (собственные данные) / Н.А. Шостак, Н.Г. Правдюк [и др.] // Современная ревматология. – 2008. – Т. 2, №3. – С. 30–35.

. [[l145]] Алексеева Л.И. Применение Пиаскледина при остеоартрозе суставов кистей / Л.И. Алексеева, Н.В. Чичасова, Н.Г. Кашеварова [и др.] // Фарматека. – 2010. – Т. 10. – С. 48–55.

. [[l146]] Lequesne M. Structural effect of avocado/soybean unsaponifiables on joint space loss in osteoarthritis of the hip / M. Lequesne, E. Maheu, C. Cadet [et al.] // Arthritis Rheum. – 2002. – Vol. 47, №1. – P. 50–58.

. [[l147]] Maheu E. Randomised, controlled trial of avocado-soybean unsaponifiable (Piascledine) effect on structure modification in hip osteoarthritis: the ERADIAS study / E. Maheu, C. Cadet, M. Marty [et al.] // Ann. Rheum. Dis. – 2014. – Vol. 73, №2. – P. 376–384.

. [[l148]] Fidelix T.S.A. Diacerein for osteoarthritis / T.S.A. Fidelix, B. Soares, V. Fernandes Moça Trevisani // Cochrane Database Syst. Rev. – 2006. – №1. – Article ID CD005117.

. [[l149]] Лила А.М. Диацереин в терапии остеоартрита коленных суставов: результаты сравнительного исследования / А.М. Лила, Л.В. Мартынова, В.А. Лила // РМЖ. Ревматология. – 2016. – №2. – С. 70–77.

. [[l150]] Балабанова Р.М. Применение диацереина для лечения остеоартроза крупных суставов (обзор литературы и собственный опыт) / Р.М. Балабанова // Современная ревматология. – 2015. – Т. 9, №3. – С. 30–32.

. [[l151]] Bartels E.M. Symptomatic efficacy and safety of diacerein in the treatment of osteoarthritis: a meta-analysis of randomized placebo-controlled trials / E.M. Bartels, H. Bliddal, P.K. Schøndorff [et al.] // Osteoarthritis Cartilage. – 2010. – Vol. 18, №3. – P. 289–296.

. [[l152]] Pelletier J.P. An international, multicentre, double-blind, randomized study (DISSCO): effect of diacerein vs celecoxib on symptoms in knee osteoarthritis / J.P. Pelletier, J.P. Raynauld, M. Dorais [et al.] // Rheumatology (Oxford). – 2020. – Vol. 59, №12. – P. 3858–3868.

. [[l153]] Li G. Efficacy, residual effectiveness and safety of diacerein in the treatment of knee osteoarthritis: A meta-analysis of randomized placebo-controlled trials / G. Li, Z. Zhang, Y. Ye [et al.] // Medicine. – 2022. – Vol. 101, №46. – Article ID e31700.

. [[l154]] Pavelka K. Diacerein: Benefits, Risks and Place in the Management of Osteoarthritis. An Opinion-Based Report from the ESCEO / K. Pavelka, O. Bruyère, C. Cooper [et al.] // Drugs Aging. – 2016. – Vol. 33, №2. – P. 75–85.

. [[l155]] Zeng F. Diacerein versus non-steroidal anti-inflammatory drugs in the treatment of knee osteoarthritis: a meta-analysis / F. Zeng, K. Wang, H. Duan [et al.] // J. Orthop. Surg. Res. – 2023. – Vol. 18, №1. – Article ID 03786-6.

. [[l156]] Dougados M. Evaluation of the structure-modifying effects of diacerein in hip osteoarthritis: ECHODIAH, a three-year, placebo-controlled trial. Evaluation of the Chondromodulating Effect of Diacerein in OA of the Hip / M. Dougados, M. Nguyen, L. Berdah [et al.] for the E.I.S.G. // Arthritis Rheum. – 2001. – Vol. 44, №11. – P. 2539–2547.

. [[l157]] Наумов А.В. Эффективность и безопасность диацереина в терапии хронической боли при остеоартрите у пациентов с сердечно-сосудистой коморбидностью и противопоказаниями к НПВП / А.В. Наумов // Поликлиника. – 2015. – С. 33–37.

. [[l158]] Шарапова Е.П. Диацереин в лечении остеоартрита у больных с коморбидностью / Е.П. Шарапова, Л.И. Алексеева, А.М. Лила [и др.] // Современная ревматология. – 2018. – Т. 12, №4. – С. 54–58.

. [[l159]] Каратеев А.Е. Оценка переносимости диацереина в реальной клинической практике. Результаты исследования РОКАДА (ретроспективная оценка клинических аспектов применения Диафлекса при остеоартрозе) / А.Е. Каратеев, Л.И. Алексеева [и др.] // Научнопрактическая ревматология. – 2015. – Т. 53, №2. – С. 169–174.

. [[l160]] Леушина, Е.А. Применение диацереина при остеоартрозе суставов кистей / Е.А. Леушина, О.В. Симонова // Лечебное дело. - 2013. - №1. – С. 62–65.

. [[l161]] Данилов А.Н. Хроническая неспецифическая боль в спине: многоцентровое исследование препарата Диафлекс / А.Н. Данилов, О.В. Курушина, А.Е. Барулин [и др.] // Manage Pain. – 2018. – С. 38–42.

. [[l162]] Shrestha R. Investigating the Efficacy and Safety of Diacerein in the Management of Knee Osteoarthritis with reference to its conventional management / R. Shrestha, S. Tamrakar, P. Koju [et al.] // J. Nepal Health Res. Counc. – 2023. – Vol. 20, №4. – P. 942–946.

. [[l163]] Xiang Y. Efficacy and safety of diacerein monotherapy in adults with obesity: A randomized, double-blind, placebo-controlled trial / Y. Xiang, L. Shen, Y. Xue [et al.] // Diabetes Obes. Metab. – 2024. – Vol. 26, №11.

. [[l164]] Алексеева Л.И. Остеоартрит коленных суставов и метаболический синдром: новые подходы к терапии / Л.И. Алексеева, Е.А. Таскина, Н.Г. Кашеварова [и др.] // Научнопрактическая ревматология. – 2018. – Т. 56, №2. – С. 157–163.

. [[l165]] Joo N.S. Changes of body weight and inflammatory markers after 12-week intervention trial: results of a double-blind, placebo-control pilot study / N.S. Joo, S.M. Kim, K.M. Kim [et al.] // Yonsei Med. J. – 2011. – Vol. 52, №2. – P. 242–248.

. [[l166]] Zhang Q. The effect and safety of diacerein in patients with type 2 diabetes mellitus: a systematic review and meta-analysis / Q. Zhang, J. Zhou, Y. Wang, D. Chen // Am. J. Clin. Exp. Immunol. – 2017. – Vol. 6, №6. – P. 97–106.

. [[l167]] Nowrouzi-Sohrabi P. Effects of Diacerein Intake on Cardiometabolic Profiles in Type 2 Diabetics: A Systematic Review and Meta-Analysis of Clinical Trials / P. Nowrouzi-Sohrabi, R. Tabrizi, M. Jalali [et al.] // Curr. Med. Chem. – 2021. – Vol. 28, №4. – P. 840–852.

. [[l168]] Guo S. The Effect of Diacerein on Type 2 Diabetic Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials with Trial Sequential Analysis / S. Guo, X. Guo, H. Zhang [et al.] // J. Diabetes Res. – 2020. – Vol. 2020. – Article ID 2593792.

. [[l169]] Honvo G. Safety of Symptomatic Slow-Acting Drugs for Osteoarthritis: Outcomes of a Systematic Review and Meta-Analysis / G. Honvo, J.Y. Reginster, V. Rabenda [et al.] // Drugs Aging. – 2019. – Vol. 36, №Suppl 1. – P. 65–99.

. [[l170]] Youn S. Efficacy and safety of diacerein and celecoxib combination therapy for knee osteoarthritis: A double-blind, randomized, placebo-controlled prospective study / S. Youn, J.H. Choi, C. Kim [et al.] // Medicine. – 2023. – Vol. 102, №39. – Article ID E35317.

. [[l171]] Лила А.М. Длительное многоцентровое наблюдательное исследование препарата Алфлутоп в России: применение у пациентов с хронической болью в спине (сообщение 3) / А.М. Лила, А.Е. Каратеев, Л.И. Алексеева [и др.] // Современная ревматология. – 2024. – Т. 18, №1. – С. 70–75.

. [[l172]] Лила А.М. Длительное многоцентровое наблюдательное исследование Алфлутопа в России: предварительные результаты (сообщение 1) / А.М. Лила, Л.И. Алексеева, Е.А. Таскина [и др.] // Современная ревматология. – 2023. – Т. 17, №2. – С. 57–64.

. [[l173]] Лила А.М. Длительное многоцентровое наблюдательное исследование препарата Алфлутоп в России (сообщение 2) / А.М. Лила, Е.А. Таскина, Л.И. Алексеева [и др.] // Современная ревматология. – 2023. – Т. 17, №4. – С. 75–85.

. [[l174]] Алексеева Л.А. Многоцентровое слепое рандомизированное плацебоконтролируемое исследование симптом- и структурно-модифицирующего действия препарата Алфлутоп у больных остеоартрозом коленных суставов. Сообщение 1 — оценка симптом-модифицирующего действия препарата / Л. И. Алексеева, Е.П. Шарапова, Е.А. Таскина [и др.] // Научно-практическая ревматология. – 2013. – Т. 51, №5.

. [[l175]] Шарапова Е.П. Многоцентровое проспективное рандомизированное исследование эффективности и безопасности препарата Алфлутоп® в альтернирующем режиме по сравнению со стандартным режимом. Сообщение 2: оценка безопасности препарата при различных схемах применения / Е.П. Шарапова, Л.И. Алексеева, Е.А. Таскина [и др.] // Современная ревматология. – 2020. – Т. 14, №1. – С. 67–73.

. [[l176]] Каратеев А.Е. Хроническая боль в спине как проявление остеоартрита позвоночника: обоснование и практика применения симптоматических средств замедленного действия / А.Е. Каратеев // Современная ревматология. – 2022. – С. 88–97.

. [[l177]] Самарцев И.Н. Оценка терапевтической эффективности Алфлутопа в комплексном лечении пациентов с хронической болью в нижней части спины (наблюдательное исследование ЦЕЙТНОТ) / И.Н. Самарцев, С.А. Живолупов, Е.Р. Баранцевич [и др.] // Журнал неврологии и психиатрии им. С.С. Корсакова. – 2021. – С. 24–30.

. [[l178]] Малышенко О.С. Оценка безопасности биоактивного концентрата мелких морских рыб у пациентов старческого возраста с остеоартритом коленного сустава и высокой коморбидностью / О.С. Малышенко, Е.А Таскина, Т.А Раскина [и др.] // Терапия. – 2023. – С. 148–155.

. [[l179]] Каратеев А.Е. Гликозаминогликан-пептидный комплекс при лечении остеоартрита коленного и тазобедренного суставов: из прошлого в будущее / А.Е. Каратеев // Научнопрактическая ревматология. – 2020. – Т. 58, №1. – С. 91–96.

. [[l180]] Каратеев А.Е. Оценка эффективности и безопасности гликозаминогликанпептидного комплекса при лечении остеоартрита коленного сустава у больных с предшествующей неэффективностью пероральных медленно действующих противовоспалительных препаратов (многоцентровое открытое исследование ПРИМУЛА: Применение Румалона® при Исходно Малом Успехе в Лечении остеоАртрита) / А.Е. Каратеев, Л.И. Алексеева, А.М. Лила [и др.] // Научно-практическая ревматология. – 2018. – Т. 56, №1. – С. 22–27.

. [[l181]] Adler E. A double blind trial with cartilage and bone marrow extract in degenerative gonarthrosis / E. Adler, E. Wolf, I. Taustein // Scand. J. Rheumatol. – 1987. – Vol. 16, №1. – P. 6–11.

. [[l182]] Katona G. A clinical trial of glycosaminoglycan-peptide complex ('Rumalon’) in patients with osteoarthritis of the knee / G. Katona // Curr. Med. Res. Opin. – 1987. – Vol. 10, №9. – P. 625–633.

. [[l183]] Gramajo R.J. A single-blind, placebo-controlled study of glycosaminoglycan-peptide complex ('Rumalon') in patients with osteoarthritis of the hip or knee / R.J. Gramajo, E.J. Cutroneo, D.E. Fernandez [et al.] // Curr. Med. Res. Opin. – 1989. – Vol. 11, №6. – P. 366–373.

. [[l184]] Rejholec V. Langzeitbehandlung der Coxarthrose mit Rumalon® / V. Rejholec, M. Králová // Aktuelle Rheumatol. – 1984. – Vol. 9. – P. 139–148.

. [[l185]] Pavelká K. A 5-year randomized controlled, double-blind study of glycosaminoglycan polysulphuric acid complex (Rumalon®) as a structure modifying therapy in osteoarthritis of the hip and knee / K. Pavelká, J. Gatterová, V. Gollerova [et al.] // Osteoarthritis Cartilage. – 2000. – Vol. 8, №5. – P. 335–342.

. [[l186]] Алексеева Л.И. Применение Румалона при гонартрозе / Л.И. Алексеева, А.Н. Карякин, А.В. Смирнов [и др.] // Терапевтический архив. – 1997. – №5. – С. 64–66.

. [[l187]] Алексеева Л.И. Многоцентровое проспективное исследование эффективности и безопасности гликозаминогликан-пептидного комплекса у пациентов с остеоартритом коленных суставов и коморбидностью / Л.И. Алексеева, Е.А. Таскина, Н.Г. Кашеварова [и др.] // Современная ревматология. – 2020. – Т. 15, №1. – С. 51–59.

. [[l188]] Kongtharvonskul J. Efficacy of glucosamine plus diacerein versus monotherapy of glucosamine: A double-blind, parallel randomized clinical trial / J. Kongtharvonskul, P. Woratanarat, M. McEvoy [et al.] // Arthritis Res. Ther. – 2016. – Vol. 18, №1. – P. 1–12.

. [[l189]] Алексеева Л.И. Оценка эффективности и безопасности инъекционной формы гликозаминогликан-пептидного комплекса у пациентов с остеоартритом: многоцентровое наблюдательное исследование ГЛАДИОЛУС / Л.И. Алексеева, А.Е. Каратеев, Е.Ю. Погожева [и др.] // Современная ревматология. – 2020. – Т. 14, №2. – С. 76–83.

. [[l190]] Алексеева Л.И. Многоцентровое проспективное исследование эффективности и безопасности гликозаминогликан-пептидного комплекса в комбинации с диацереином у пациентов с остеоартритом коленных суставов / Л.И. Алексеева, А.М. Лила, Е.П. Шарапова [и др.] // Терапия. – 2022. – №2. – С. 6–18.

. [[l191]] Каратеев А.Е. Эффективность и безопасность комбинированного применения целекоксиба, диацереина и комбинации глюкозамина и хондроитина для контроля скелетно-мышечной боли, связанной с остеоартритом и неспецифической болью в спине / А.Е. Каратеев, Е.Ю. Полищук, А.М. Лила [и др.] // Соврем. ревматол. – 2023. – Т. 17, №5. – С. 97–106.

. [[l192]] American Academy of Orthopaedic Surgeons. Management of osteoarthritis of the hip: evidence-based clinical practice guideline [Электронный ресурс] / American Academy of Orthopaedic Surgeons. – 2017. – URL: https://www.aaos.org/globalassets/quality-and-practiceresources/osteoarthritis-of-the-hip/oa-hip-cpg_6-11-19.pdf (дата обращения: 06.03.2025).

. [[l193]] Wolff D.G. Topical nonsteroidal anti-inflammatory drugs in the treatment of knee osteoarthritis: a systematic review and meta-analysis / D.G. Wolff, C. Christophersen, S.M. Brown [et al.] // Physician Sportsmed. – 2021. – Vol. 49, №4. – P. 381–391.

. [[l194]] Overton C. Osteoarthritis Treatment Guidelines from Six Professional Societies: Similarities and Differences / C. Overton, A.E. Nelson, T. Neogi // Rheum. Dis. Clin. North Am. – 2022. – Vol. 48, №3. – P. 637–657.

. [[l195]] Лила А.М. Нестероидные противовоспалительные препараты при остеоартрите и неспецифической боли в спине: основные положения по эффективному и безопасному применению (междисциплинарный консенсус) / А.М. Лила, Н.В. Загородний, Л.И. Алексеева [и др.] // Соврем. ревматол. – 2024. – Т. 18, №6. – С. 114–123.

. [[l196]] Кашеварова Н.Г. Проспективное сравнительное рандомизированное исследование эффективности и безопасности топических форм теноксикама и диклофенака у пациентов с остеоартритом коленных суставов / Н.Г. Кашеварова, Е.А. Таскина, Е.А. Стребкова [и др.] // Современная ревматология. – 2023. – Т. 17, №3. – С. 51–59.

. [[l197]] Zeng C. Relative efficacy and safety of topical non-steroidal anti-inflammatory drugs for osteoarthritis: a systematic review and network meta-analysis of randomised controlled trials and observational studies / C. Zeng, J. Wei, M.S.M. Persson [et al.] // Br. J. Sports Med. – 2018. – Vol. 52, №10. – P. 642–650.

. [[l198]] Honvo G. Safety of Topical Non-steroidal Anti-Inflammatory Drugs in Osteoarthritis: Outcomes of a Systematic Review and Meta-Analysis / G. Honvo, V. Leclercq, A. Geerinck [et al.] // Drugs Aging. – 2019. – Vol. 36, №Suppl 1. – P. 45–64.

. [[l199]] Persson M.S.M. Predicting response to topical non-steroidal anti-inflammatory drugs in osteoarthritis: an individual patient data meta-analysis of randomized controlled trials / M.S.M. Persson, J. Stocks, G. Varadi [et al.] // Rheumatology (Oxford). – 2020. – Vol. 59, №9. – P. 2207–2216.

. [[l200]] Shi C. Multidisciplinary Guidelines for the Rational Use of Topical Non-Steroidal AntiInflammatory Drugs for Musculoskeletal Pain (2022) / C. Shi, Z. Ye, Z. Shao [et al.] // J. Clin. Med. – 2023. – Vol. 12, №4. – Article ID 1544.

. [[l201]] Wang Y. Relative safety and efficacy of topical and oral NSAIDs in the treatment of osteoarthritis: A systematic review and meta-analysis / Y. Wang, M. Fan, H. Wang [et al.] // Medicine. – 2022. – Vol. 101, №36. – Article ID E30354.

. [[l202]] Lee J.K. Topical nonsteroidal anti-inflammatory drugs for management of osteoarthritis pain: A consensus recommendation / J.K. Lee, A.A. Abbas, T.E. Cheah [et al.] // J. Orthop. Res. – 2023. – Vol. 41, №9. – P. 1916–1924.

. [[l203]] Hagen M. Skin penetration and tissue permeation after topical administration of diclofenac / M. Hagen, M. Baker // Curr. Med. Res. Opin. – 2017. – Vol. 33, №9. – P. 1623–1634.

. [[l204]] Figueras A. Spontaneous reporting of adverse drug reactions to non-steroidal antiinflammatory drugs. A report from the Spanish System of Pharmacovigilance, including an early analysis of topical and enteric-coated formulations / A. Figueras, D. Capellà, J.M. Castel [et al.] // Eur. J. Clin. Pharmacol. – 1994. – Vol. 47, №4. – P. 297–303.

. [[l205]] Barkin R.L. Topical Nonsteroidal Anti-Inflammatory Drugs: The Importance of Drug, Delivery, and Therapeutic Outcome / R.L. Barkin // Am. J. Ther. – 2015. – Vol. 22, №5. – P. 388–407.

. [[l206]] Каратеев А.Е. Рациональное использование нестероидных противовоспалительных препаратов. Клинические рекомендации / А.Е. Каратеев, Е.Л. Насонов, В.Т. Ивашкин [и др.] // Научно-практическая ревматология. – 2018. – Т. 56, №0. – С. 1–29.

. [[l207]] Таскина Е.А. Место нестероидных противовоспалительных препаратов в современных рекомендациях по остеоартриту / Е.А. Таскина, Н.Г. Кашеварова, Л.И. Алексеева // Современная ревматология. – 2020. – Т. 14, №2. – С. 123–130.

. [[l208]] Geenen R. EULAR recommendations for the health professional’s approach to pain management in inflammatory arthritis and osteoarthritis / R. Geenen, C.L. Overman, R. Christensen [et al.] // Ann. Rheum. Dis. – 2018. – Vol. 77, №6. – P. 797–807.

. [[l209]] Osani M.C. Duration of symptom relief and early trajectory of adverse events for oral NSAIDs in knee osteoarthritis: a systematic review and meta-analysis / M.C. Osani, E.E. Vaysbrot, M. Zhou [et al.] // Arthritis Care Res (Hoboken). – 2020. – Vol. 72, №5. – Article AD 641.

. [[l210]] Jarupongprapa S. Comparison of gastrointestinal adverse effects between cyclooxygenase2 inhibitors and non-selective, non-steroidal anti-inflammatory drugs plus proton pump inhibitors: a systematic review and meta-analysis / S. Jarupongprapa, P. Ussavasodhi, W. Katchamart // J. Gastroenterol. – 2013. – Vol. 48, №7. – P. 830–838.

. [[l211]] Trelle S. Cardiovascular safety of non-steroidal anti-inflammatory drugs: network metaanalysis / S. Trelle, S. Reichenbach, S. Wandel [et al.] // BMJ. – 2011. – Vol. 342, №7789. – Article AD 154.

. [[l212]] Grosser T. The cardiovascular pharmacology of nonsteroidal anti-inflammatory drugs / T. Grosser, E. Ricciotti, G.A. FitzGerald // Trends Pharmacol Sci. – 2017. – Vol. 38, №8. – P. 733– 748.

. [[l213]] Richard M.J. Pharmaceutical treatment of osteoarthritis / M.J. Richard, J.B. Driban, T.E. McAlindon // Osteoarthritis Cartilage. – 2023. – Vol. 31, №4. – P. 458–466.

. [[l214]] Leopoldino A.O. Paracetamol versus placebo for knee and hip osteoarthritis / A.O. Leopoldino, G.C. MacHado, P.H. Ferreira [et al.] // Cochrane Database Syst Rev. – 2019. – Vol. 2, №2. – Article AD CD013273.

. [[l215]] Zeng C. Comparative efficacy and safety of acetaminophen, topical and oral non-steroidal anti-inflammatory drugs for knee osteoarthritis: evidence from a network meta-analysis of randomized controlled trials and real-world data / C. Zeng, M. Doherty, M.S.M. Persson [et al.] // Osteoarthritis Cartilage. – 2021. – Vol. 29, №9. – P. 1242–1251.

. [[l216]] Moretti A. The challenge of pharmacotherapy for musculoskeletal pain: an overview of unmet needs / A. Moretti, F. Snichelotto, S. Liguori [et al.] // Ther Adv Musculoskelet Dis. – 2024. – Vol. 16. – Article ID 1759720X241253656.

. [[l217]] Machado G.C. Efficacy and safety of paracetamol for spinal pain and osteoarthritis: systematic review and meta-analysis of randomised placebo controlled trials / G.C. Machado, C.G. Maher, P.H. Ferreira [et al.] // BMJ. – 2015. – Vol. 350. – Article ID h1225.

. [[l218]] Roberts E. Paracetamol: not as safe as we thought? A systematic literature review of observational studies / E. Roberts, V.D. Nunes, S. Buckner [et al.] // Ann Rheum Dis. – 2016. – Vol. 75, №3. – P. 552–559.

. [[l219]] da Costa B.R. Effectiveness of non-steroidal anti-inflammatory drugs for the treatment of pain in knee and hip osteoarthritis: a network meta-analysis / B.R. da Costa, S. Reichenbach, N. Keller [et al.] // Lancet. – 2017. – Vol. 390, №10090. – P. e21–e33.

. [[l220]] Blieden M. A perspective on the epidemiology of acetaminophen exposure and toxicity in the United States / M. Blieden, L.C. Paramore, D. Shah, R. Ben-Joseph // Expert Rev Clin Pharmacol. – 2014. – Vol. 7, №3. – P. 341–348.

. [[l221]] Conaghan P.G. Safety of Paracetamol in Osteoarthritis: What Does the Literature Say? / P.G. Conaghan, N. Arden, B. Avouac [et al.] // Drugs Aging. – 2019. – Vol. 36, №Suppl 1. – P. 7–14.

. [[l222]] American Academy of Orthopaedic Surgeons. Quality ID #109: Osteoarthritis (OA): Function and Pain Assessment — National Quality Strategy Domain: Person and Caregiver-Centered Experience and Outcomes [Электронный ресурс]. – 2025. – URL: https://www.aaos.org/globalassets/quality-and-practice-resources/osteoarthritis-of-thehip/measure-109-specifications.pdf (дата обращения: 06.03.2025).

. [[l223]] Food and Drug Administration. Acetaminophen Label [Электронный ресурс]. – 2022. – URL: www.fda.gov/medwatch (дата обращения: 06.03.2025).

. [[l224]] Hunter D.J. Osteoarthritis: Yet another death knell for paracetamol in OA / D.J. Hunter, M.L. Ferreira // Nat Rev Rheumatol. – 2016. – Vol. 12, №6. – P. 320-321.

. [[l225]] Doherty M. A randomised controlled trial of ibuprofen, paracetamol or a combination tablet of ibuprofen/paracetamol in community-derived people with knee pain / M. Doherty, C. Hawkey, M. Goulder [et al.] // Ann Rheum Dis. – 2011. – Vol. 70, №9. – P. 1534–1541.

. [[l226]] Rahme E. Hospitalizations for upper and lower GI events associated with traditional NSAIDs and acetaminophen among the elderly in Quebec, Canada / E. Rahme, A. Barkun, H. Nedjar [et al.] // Am J Gastroenterol. – 2008. – Vol. 103, №4. – P. 872–882.

. [[l227]] Curhan G.C. Lifetime nonnarcotic analgesic use and decline in renal function in women / G.C. Curhan, E.L. Knight, B. Rosner [et al.] // Arch Intern Med. – 2004. – Vol. 164, №14. – P. 1519–1524.

. [[l228]] Curhan G.C. Frequency of analgesic use and risk of hypertension in younger women / G.C. Curhan, W.C. Willett, B. Rosner [et al.] // Arch Intern Med. – 2002. – Vol. 162, №19. – P. 2204–2208.

. [[l229]] Zhang X. Efficacy and Safety of Tramadol for Knee or Hip Osteoarthritis: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials / X. Zhang, X. Li, Y. Xiong [et al.] // Arthritis Care Res (Hoboken). – 2023. – Vol. 75, №1. – P. 158–165.

. [[l230]] April K.T. Tramadol for osteoarthritis / K.T. April, J. Bisaillon, V. Welch [et al.] // Cochrane Database Syst Rev. – 2019. – Vol. 5, №5. – Article ID CD005522.PUB3.

. [[l231]] Busse J.W. Opioids for Chronic Noncancer Pain: A Systematic Review and Meta-analysis / J.W. Busse, L. Wang, M. Kamaleldin [et al.] // JAMA. – 2018. – Vol. 320, №23. – P. 2448–2460.

. [[l232]] Nicholas E. Non-operative Treatment Options for Osteoarthritis in the Hip / E. Nicholas, J. Cheng, P.J. Moley // HSS J. – 2023. – Vol. 19, №4. – P. 486–493.

. [[l233]] Zeng C. Association of Tramadol With All-Cause Mortality Among Patients With Osteoarthritis / C. Zeng, M. Dubreuil, M.R. Larochelle [et al.] // JAMA. – 2019. – Vol. 321, №10. – P. 969–982.

. [[l234]] Li L. Association of tramadol with all-cause mortality, cardiovascular diseases, venous thromboembolism, and hip fractures among patients with osteoarthritis: a population-based study / L. Li, S. Marozoff, N. Lu [et al.] // Arthritis Res Ther. – 2022. – Vol. 24, №1.

. [[l235]] Rahimi H.R. Acute tramadol poisoning and its clinical and laboratory findings / H.R. Rahimi, K. Soltaninejad, S. Shadnia // J Res Med Sci. – 2014. – Vol. 19, №9. – P. 855–859.

. [[l236]] Nakhaee S. A review on tramadol toxicity: mechanism of action, clinical presentation, and treatment / S. Nakhaee, C. Hoyte, R.C. Dart [et al.] // Forensic Toxicol. – 2021. – Vol. 39. – P. 293–310.

. [[l237]] Beakley B.D. Tramadol, Pharmacology, Side Effects, and Serotonin Syndrome: A Review / B.D. Beakley, K.A. Kaye, R.D. Kaye // Pain Physician. – 2015. – Vol. 18, №4. – P. 395–400.

. [[l238]] Narayan S.W. Efficacy and safety of antidepressants for pain in older adults: A systematic review and meta-analysis / S.W. Narayan, V. Naganathan, L. Vizza [et al.] // Br J Clin Pharmacol. – 2024. – Vol. 90, №12. – P. 3097–3118.

. [[l239]] Leaney A.A. Antidepressants for hip and knee osteoarthritis / A.A. Leaney, J.R. Lyttle, J. Segan [et al.] // Cochrane Database Syst Rev. – 2022. – Vol. 10, №10. – Article ID CD012157.

. [[l240]] Uchio Y. A randomized, double-blind, placebo-controlled Phase III trial of duloxetine in Japanese patients with knee pain due to osteoarthritis / Y. Uchio, H. Enomoto, L. Alev [et al.] // J Pain Res. – 2018. – Vol. 11. – P. 809–821.

. [[l241]] Risser R.C. Responsiveness of the Intermittent and Constant Osteoarthritis Pain (ICOAP) scale in a trial of duloxetine for treatment of osteoarthritis knee pain / R.C. Risser, M.C. Hochberg, P.J. Gaynor [et al.] // Osteoarthritis Cartilage. – 2013. – Vol. 21, №5. – P. 691–694.

. [[l242]] Osani M.C. Efficacy and safety of duloxetine in osteoarthritis: a systematic review and meta-analysis / M.C. Osani, R.R. Bannuru // Korean J Intern Med. – 2019. – Vol. 34, №5. – P. 966–973.

. [[l243]] Gao S.H. The short-term effect and safety of duloxetine in osteoarthritis: A systematic review and meta-analysis / S.H. Gao, J. Bin Huo, Q.M. Pan [et al.] // Medicine. – 2019. – Vol. 98, №44. – Article ID 17541.

. [[l244]] Weng C. Efficacy and safety of duloxetine in osteoarthritis or chronic low back pain: a systematic review and meta-analysis / C. Weng, J. Xu, Q. Wang [et al.] // Osteoarthritis Cartilage. – 2020. – Vol. 28, №6. – P. 721–734.

. [[l245]] Pergolizzi J.V. A review of duloxetine 60 mg once-daily dosing for the management of diabetic peripheral neuropathic pain, fibromyalgia, and chronic musculoskeletal pain due to chronic osteoarthritis pain and low back pain / J.V. Pergolizzi, R.B. Raffa, R. Taylor [et al.] // Pain Pract. – 2013. – Vol. 13, №3. – P. 239–252.

. [[l246]] Филатова Е.С. Эффективность и безопасность комбинированной терапии ацеклофенаком и прегабалином хронического болевого синдрома у пациентов с остеоартритом коленных суставов / Е.С. Филатова, Л.И. Алексеева, Е.А. Таскина [и др.] // Фарматека. – 2020. – С. 101–107.

. [[l247]] Wiffen P.J. Gabapentin for chronic neuropathic pain in adults / P.J. Wiffen, S. Derry, R.F. Bell [et al.] // Cochrane Database Syst Rev. – 2017. – Vol. 6, №6. – Article ID CD007938.

. [[l248]] Enteshari-Moghaddam A. Efficacy of duloxetine and gabapentin in pain reduction in patients with knee osteoarthritis / A. Enteshari-Moghaddam, A. Azami, K. Isazadehfar [et al.] // Clin Rheumatol. – 2019. – Vol. 38, №10. – P. 2873–2880.

. [[l249]] Филатова Е.С. Нейрогенные механизмы хронической суставной боли: дис. д-ра мед. наук: 14.01.11 – Нервные болезни и 3.1.27 (14.01.22) – Ревматология / Е.С. Филатова; ФГАОУ ВО Первый Московский государственный медицинский университет имени И.М. Сеченова. – Москва, 2021.

. [[l250]] Van Den Driest J.J. Antidepressant and anticonvulsant prescription rates in patients with osteoarthritis: a population-based cohort study / J.J. Van Den Driest, D. Schiphof, M. De Wilde [et al.] // Rheumatology (Oxford). – 2021. – Vol. 60, №5. – P. 2206–2216.

. [[l251]] Ohtori S. Efficacy of combination of meloxicam and pregabalin for pain in knee osteoarthritis / S. Ohtori, G. Inoue, S. Orita [et al.] // Yonsei Med J. – 2013. – Vol. 54, №5. – P. 1253–1258.

. [[l252]] Sofat N. The effect of pregabalin or duloxetine on arthritis pain: a clinical and mechanistic study in people with hand osteoarthritis / N. Sofat, A. Harrison, M.D. Russell [et al.] // J Pain Res. – 2017. – Vol. 10. – P. 2437-2449.

. [[l253]] Shaheen A. Clinical efficacy and tolerability of Gabapentinoids with current prescription patterns in patients with Neuropathic pain / A. Shaheen, S.M. Alam, A. Ahmad [et al.] // Pak J Med Sci. – 2019. – Vol. 35, №6. – P. 1505-1510.

. [[l254]] Molero Y. Associations between gabapentinoids and suicidal behaviour, unintentional overdoses, injuries, road traffic incidents, and violent crime: population based cohort study in Sweden / Y. Molero, H. Larsson, B.M. D’Onofrio [et al.] // BMJ. – 2019. – Vol. 365. – Article ID L2147.

. [[l255]] FDA. Full Prescribing Information: Neurontin (gabapentin) [Электронный ресурс] // http://www.fda.gov/medwatch (дата обращения: 06.03.2025).

. [[l256]] Evoy K.E. Reports of gabapentin and pregabalin abuse, misuse, dependence, or overdose: An analysis of the Food And Drug Administration Adverse Events Reporting System (FAERS) / K.E. Evoy, J.R. Covvey, A.M. Peckham [et al.] // Res Social Adm Pharm. – 2019. – Vol. 15, №8. – P. 953–958.

. [[l257]] Zhong H.M. Intra-Articular Steroid Injection for Patients with Hip Osteoarthritis: A Systematic Review and Meta-Analysis / H.M. Zhong, G.F. Zhao, T. Lin [et al.] // Biomed Res Int. – 2020. – Vol. 2020. – Article ID 6320154.

. [[l258]] Jüni P. Intra-articular corticosteroid for knee osteoarthritis / P. Jüni, R. Hari, A.W.S. Rutjes [et al.] // Cochrane Database Syst Rev. – 2015. – Vol. 2015, №10. – Article ID CD005328.

. [[l259]] Stout A. Systemic Absorption and Side Effects of Locally Injected Glucocorticoids / A. Stout, J. Friedly, C.J. Standaert // PM R. – 2019. – Vol. 11, №4. – P. 409–419.

. [[l260]] Guermazi A. Intra-articular Corticosteroid Injections for the Treatment of Hip and Knee Osteoarthritis-related Pain: Considerations and Controversies with a Focus on Imaging-Radiology Scientific Expert Panel / A. Guermazi, T. Neogi, J.N. Katz [et al.] // Radiology. – 2020. – Vol. 297, №3. – P. 503–512.

. [[l261]] McAlindon T.E. Effect of Intra-articular Triamcinolone vs Saline on Knee Cartilage Volume and Pain in Patients With Knee Osteoarthritis: A Randomized Clinical Trial / T.E. McAlindon, M.P. LaValley, W.F. Harvey [et al.] // JAMA. – 2017. – Vol. 317, №19. – P. 1967–1975.

. [[l262]] Miller L.E. Safety of Intra-Articular Hyaluronic Acid for Knee Osteoarthritis: Systematic Review and Meta-Analysis of Randomized Trials Involving More than 8,000 Patients / L.E. Miller, S. Bhattacharyya, W.R. Parrish [et al.] // Cartilage. – 2021. – Vol. 13, №1_suppl. – P. 351S-363S.

. [[l263]] Campbell K.A. Is Local Viscosupplementation Injection Clinically Superior to Other Therapies in the Treatment of Osteoarthritis of the Knee: A Systematic Review of Overlapping Meta-analyses / K.A. Campbell, B.J. Erickson, B.M. Saltzman [et al.] // Arthroscopy. – 2015. – Vol. 31, №10. – P. 2036-2045.

. [[l264]] Стребкова Е.А. Эффективность внутрисуставной терапии препаратами гиалуроновой кислоты у больных остеоартритом / Е.А. Стребкова, Л.И. Алексеева // Современная ревматология. – 2019. – Т. 13, №2. – С. 96–104.

. [[l265]] Hummer C.D. High molecular weight Intraarticular hyaluronic acid for the treatment of knee osteoarthritis: a network meta-analysis / C.D. Hummer, F. Angst, W. Ngai [et al.] // BMC Musculoskelet Disord. – 2020. – Vol. 21, №1. – Article ID S12891-020-03729-W.

. [[l266]] Concoff A. The efficacy of multiple versus single hyaluronic acid injections: a systematic review and meta-analysis / A. Concoff, P. Sancheti, F. Niazi [et al.] // BMC Musculoskelet Disord. – 2017. – Vol. 18, №1. – Article ID S12891-017-1897-2.

. [[l267]] Altman R. Efficacy and safety of repeated courses of hyaluronic acid injections for knee osteoarthritis: A systematic review / R. Altman, J. Hackel, F. Niazi [et al.] // Semin Arthritis Rheum. – 2018. – Vol. 48, №2. – P. 168–175.

. [[l268]] Wu Y.Z. Molecular Weight of Hyaluronic Acid Has Major Influence on Its Efficacy and Safety for Viscosupplementation in Hip Osteoarthritis: A Systematic Review and Meta-Analysis / Y.Z. Wu, H.T. Huang, C.J. Ho [et al.] // Cartilage. – 2021. – Vol. 13, №1. – P. 169S-184S.

. [[l269]] Migliore A. Systematic Literature Review and Expert Opinion for the Use of Viscosupplementation with Hyaluronic Acid in Different Localizations of Osteoarthritis / A. Migliore, G. Gigliucci, L. Alekseeva [et al.] // Orthop Res Rev. – 2021. – Vol. 13. – P. 255–273.

. [[l270]] Hoeber S. Ultrasound-guided hip joint injections are more accurate than landmark-guided injections: a systematic review and meta-analysis / S. Hoeber, A.R. Aly, N. Ashworth [et al.] // Br J Sports Med. – 2016. – Vol. 50, №7. – P. 392–396.

. [[l271]] Ruiz Santiago F. Ultrasound guided procedures in the musculoskeletal system: a narrative review with illustrative examples / F. Ruiz Santiago, C. Orellana González, B. Moraleda Cabrera [et al.] // Quant Imaging Med Surg. – 2024. – Vol. 14, №11. – P. 8028–8049.

. [[l272]] Лила А.М. Локальная инъекционная терапия в комплексном лечении болезней костно-мышечной системы: основные принципы использования, доказательная база, безопасность / А.М. Лила, Н.В. Загородний, А.Е. Каратеев [и др.] // Современная ревматология. – 2023. – Т. 17, №4. – С. 120–137.

. [[l273]] Cooper C. Use of Intraarticular Hyaluronic Acid in the Management of Knee Osteoarthritis in Clinical Practice / C. Cooper, F. Rannou, P. Richette [et al.] // Arthritis Care Res (Hoboken). – 2017. – Vol. 69, №9. – P. 1287–1296.

. [[l274]] Monfort J. Comparative efficacy of intra-articular hyaluronic acid and corticoid injections in osteoarthritis of the first carpometacarpal joint: results of a 6-month single-masked randomized study / J. Monfort, D. Rotés-Sala, N. Segalés [et al.] // Joint Bone Spine. – 2015. – Vol. 82, №2. – P. 116–121.

. [[l275]] Oo W.M. Efficacy, Safety, and Accuracy of Intra-articular Therapies for Hand Osteoarthritis: Current Evidence / W.M. Oo, D.J. Hunter // Drugs Aging. – 2023. – Vol. 40, №1. – P. 1–20.

. [[l276]] Thakker A. Comparison between intra-articular injections of corticosteroids, hyaluronic acid, PRP and placebo for thumb base osteoarthritis: A frequentist network meta-analysis / A. Thakker, S.C. Sharma, N. Johnson [et al.] // J Orthop. – 2023. – Vol. 45. – P. 78–86.

. [[l277]] Papalia R. Intrarticular injections of hyaluronic acid for trapezio-metacarpal osteoarthritis: a systematic review / R. Papalia, L.A. Diaz, G. Torre [et al.] // J Biol Regul Homeost Agents. – 2017. – Vol. 31, №4 Suppl 2. – P. 45–53.

. [[l278]] Munteanu S.E. Effectiveness of intra-articular hyaluronan (Synvisc, hylan G-F 20) for the treatment of first metatarsophalangeal joint osteoarthritis: a randomised placebo-controlled trial / S.E. Munteanu, G.V. Zammit, H.B. Menz [et al.] // Ann Rheum Dis. – 2011. – Vol. 70, №10. – P. 1838–1841.

. [[l279]] Бялик В.Е. Изучение эффективности локальной инъекционной терапии препаратами гиалуроновой кислоты различной молекулярной массы у больных остеоартритом коленного сустава / В.Е. Бялик, И.Б. Еременко, А.А. Малышева [и др.] // Научнопрактическая ревматология. – 2019. – Т. 57, №2. – С. 235–242.

. [[l280]] Sahi G. Current state of systematic reviews for platelet-rich plasma use in knee osteoarthritis / G. Sahi, J.T. Du, A. Abbas [et al.] // Orthop Traumatol Surg Res. – 2024. – Vol. 110, №1. – Article ID 103735.

. [[l281]] Migliorini F. Comparison between intra-articular infiltrations of placebo, steroids, hyaluronic and PRP for knee osteoarthritis: a Bayesian network meta-analysis / F. Migliorini, A. Driessen, V. Quack [et al.] // Arch Orthop Trauma Surg. – 2021. – Vol. 141, №9. – P. 1473–1490.

. [[l282]] Shahbaz A. Efficacy of Platelet-Rich Plasma Intra-articular Injections in Hip and Knee Osteoarthritis / A. Shahbaz, A. Alzarooni, V.R. Veeranagari [et al.] // Cureus. – 2024. – Vol. 16, №9. – Article ID 69656.

. [[l283]] Sax O.C. The Efficacy of Platelet-Rich Plasma for the Treatment of Knee Osteoarthritis Symptoms and Structural Changes: A Systematic Review and Meta-Analysis / O.C. Sax, Z. Chen, M.A. Mont [et al.] // J Arthroplasty. – 2022. – Vol. 37, №11. – P. 2282-2290.

. [[l284]] McLarnon M. Intra-articular platelet-rich plasma injections versus intra-articular corticosteroid injections for symptomatic management of knee osteoarthritis: systematic review and meta-analysis / M. McLarnon, N. Heron // BMC Musculoskelet Disord. – 2021. – Vol. 22, №1. – Article ID 4308.

. [[l285]] Belk J.W. Platelet-Rich Plasma Versus Hyaluronic Acid for Hip Osteoarthritis Yields Similarly Beneficial Short-Term Clinical Outcomes: A Systematic Review and Meta-analysis of Level I and II Randomized Controlled Trials / J.W. Belk, D.A. Houck, C.P. Littlefield [et al.] // Arthroscopy. – 2022. – Vol. 38, №6. – P. 2035–2046.

. [[l286]] Lim A. The Use of Intra-articular Platelet-Rich Plasma as a Therapeutic Intervention for Hip Osteoarthritis: A Systematic Review and Meta-analysis / A. Lim, J.B. Zhu, V. Khanduja // Am J Sports Med. – 2023. – Vol. 51, №9. – P. 2487–2497. – Article ID 03635465221095563.

. [[l287]] Zhao Z. Different Intra-articular Injections as Therapy for Hip Osteoarthritis: A Systematic Review and Network Meta-analysis / Z. Zhao, J. Ma Xiong, X. Ma Long // Arthroscopy. – 2020. – Vol. 36, №5. – P. 1452-1464.

. [[l288]] Khalid S. Comparative effectiveness of intra-articular therapies in knee osteoarthritis: a meta-analysis comparing platelet-rich plasma (PRP) with other treatment modalities / S. Khalid, A. Ali, F. Deepak [et al.] // Ann Med Surg (Lond). – 2023. – Vol. 86, №1. – P. 361–372.

. [[l289]] Winter R. Minimally Invasive Treatment of Trapeziometacarpal Osteoarthritis: Results of a Blinded Randomized Controlled Trial / R. Winter, A.C. Tuca, I. Justich [et al.] // Plast Reconstr Surg. – 2023. – Vol. 152, №6. – P. 1277–1285.

. [[l290]] D’Souza R. Evidence-Based Clinical Practice Guidelines on Regenerative Medicine Treatment for Chronic Pain: A Consensus Report from a Multispecialty Working Group / R. D’Souza, Y. Her, N. Hussain [et al.] // J Pain Res. – 2024. – Vol. 17. – P. 2951–3001.

. [[l291]] Datta S. Systematic assessment of diagnostic accuracy and therapeutic utility of lumbar facet joint interventions / S. Datta, M. Lee, F.J. Falco [et al.] // Pain Physician. – 2009. – Vol. 12, №2. – P. 437–460.

. [[l292]] Wu J. A New Technique for the Treatment of Lumbar Facet Joint Syndrome Using Intraarticular Injection with Autologous Platelet Rich Plasma / J. Wu, Z. Du, Y. Lv [et al.] // Pain Physician. – 2016. – Vol. 19, №8. – P. 617–625.

. [[l293]] Kirchner F. Intradiscal and intra-articular facet infiltrations with plasma rich in growth factors reduce pain in patients with chronic low back pain / F. Kirchner, E. Anitua // J Craniovertebr Junction Spine. – 2016. – Vol. 7, №4. – P. 250-256.

. [[l294]] Wu J. A Prospective Study Comparing Platelet-Rich Plasma and Local Anesthetic (LA)/Corticosteroid in Intra-Articular Injection for the Treatment of Lumbar Facet Joint Syndrome / J. Wu, J. Zhou, C. Liu [et al.] // Pain Pract. – 2017. – Vol. 17, №7. – P. 914–924.

. [[l295]] Бывальцев В.A. Анализ клинической эффективности терапии обогащенной тромбоцитами плазмой у пациентов с изолированным фасет-синдромом поясничного отдела позвоночника / В.А. Бывалцев, А.А. Калинин, А.К. Оконешникова, Э.Э. Сатардинова // Журнал неврологии и психиатрии имени С.С. Корсакова. – 2019. – Т. 119, №11. – С. 27–31.

. [[l296]] Moraes V.Y. Platelet-rich therapies for musculoskeletal soft tissue injuries / V.Y. Moraes, M. Lenza, M.J. Tamaoki [et al.] // Cochrane Database Syst Rev. – 2013. – Vol. 2013, №12. – Article ID CD010071.

. [[l297]] Gazendam A. Intra-articular saline injection is as effective as corticosteroids, platelet-rich plasma and hyaluronic acid for hip osteoarthritis pain: a systematic review and network metaanalysis of randomised controlled trials / A. Gazendam, S. Ekhtiari, A. Bozzo [et al.] // Br J Sports Med. – 2021. – Vol. 55, №5. – P. 256–261.

. [[l298]] Peng Y.N. Intra-Articular Leukocyte-Rich Platelet-Rich Plasma versus Intra-Articular Hyaluronic Acid in the Treatment of Knee Osteoarthritis: A Meta-Analysis of 14 Randomized Controlled Trials / Y.N. Peng, J.L. Chen, C.C. Hsu [et al.] // Pharmaceuticals (Basel). – 2022. – Vol. 15, №8. – Article ID 974.

. [[l299]] Pak J. Cartilage Regeneration in Human with Adipose Tissue-Derived Stem Cells: Current Status in Clinical Implications / J. Pak, J.H. Lee, W.A. Kartolo [et al.] // Biomed Res Int. – 2016. – Article ID 4702674.

. [[l300]] Yokota N. Comparative Clinical Outcomes After Intra-articular Injection With AdiposeDerived Cultured Stem Cells or Noncultured Stromal Vascular Fraction for the Treatment of Knee Osteoarthritis / N. Yokota, M. Hattori, T. Ohtsuru [et al.] // Am J Sports Med. – 2019. – Vol. 47, №11. – P. 2577–2583.

. [[l301]] Heidari N. Comparison of the Effect of MFAT and MFAT + PRP on Treatment of Hip Osteoarthritis: An Observational, Intention-to-Treat Study at One Year / N. Heidari, M. Slevin, Y. Zeinolabediny [et al.] // J Clin Med. – 2022. – Vol. 11, №4. – Article ID 1056.

. [[l302]] Natali S. Is intra-articular injection of autologous micro-fragmented adipose tissue effective in hip osteoarthritis? A three year follow-up / S. Natali, D. Screpis, M. Romeo [et al.] // Int Orthop. – 2023. – Vol. 47, №6. – P. 1487–1492.

. [[l303]] Centeno C. A specific protocol of autologous bone marrow concentrate and platelet products versus exercise therapy for symptomatic knee osteoarthritis: A randomized controlled trial with 2 year follow-up / C. Centeno, M. Sheinkop, E. Dodson [et al.] // J Transl Med. – 2018. – Vol. 16, №1. – P. 1–10.

. [[l304]] Hernigou P. Subchondral bone or intra-articular injection of bone marrow concentrate mesenchymal stem cells in bilateral knee osteoarthritis: what better postpone knee arthroplasty at fifteen years? A randomized study / P. Hernigou, C. Bouthors, C. Bastard [et al.] // Int Orthop. – 2021. – Vol. 45, №2. – P. 391–399.

. [[l305]] Hernigou P. Human bone marrow mesenchymal stem cell injection in subchondral lesions of knee osteoarthritis: a prospective randomized study versus contralateral arthroplasty at a mean fifteen year follow-up / P. Hernigou, J. Delambre, S. Quiennec [et al.] // Int Orthop. – 2021. – Vol. 45, №2. – P. 365–373.

. [[l306]] Shapiro S.A. A Prospective, Single-Blind, Placebo-Controlled Trial of Bone Marrow Aspirate Concentrate for Knee Osteoarthritis / S.A. Shapiro, S.E. Kazmerchak, M.G. Heckman [et al.] // Am J Sports Med. – 2017. – Vol. 45, №1. – P. 82–90.

. [[l307]] Wilson J.E. Safety of bone marrow derived mesenchymal stem cell extracellular vesicle injection for lumbar facet joint pain / J.E. Wilson, B.A. Today, M. Salazar [et al.] // Regenerative Med. – 2024. – Vol. 19, №1. – P. 19–26.

. [[l308]] Herberts C.A. Risk factors in the development of stem cell therapy / C.A. Herberts, M.S.G. Kwa, H.P.H. Hermsen // J Transl Med. – 2011. – Vol. 9. – Article ID 29.

. [[l309]] Barbieri A. Effects of clinical pathways in the joint replacement: a meta-analysis / A. Barbieri, K. Vanhaecht, P. Van Herck [et al.] // BMC Med. – 2009. – Vol. 7. – Article ID 32.

. [[l310]] Gooch K. Comparative effectiveness of alternative clinical pathways for primary hip and knee joint replacement patients: a pragmatic randomized, controlled trial / K. Gooch, D.A. Marshall, P.D. Faris [et al.] // Osteoarthritis Cartilage. – 2012. – Vol. 20, №10. – P. 1086–1094.

. [[l311]] Van Herck P. Key interventions and outcomes in joint arthroplasty clinical pathways: a systematic review / P. Van Herck, K. Vanhaecht, S. Deneckere [et al.] // J Eval Clin Pract. – 2010. – Vol. 16, №1. – P. 39–49.

. [[l312]] Gibson J.N.A. Arthrodesis or total replacement arthroplasty for hallux rigidus: a randomized controlled trial / J.N.A. Gibson, C.E. Thomson // Foot Ankle Int. – 2005. – Vol. 26, №9. – P. 680–690.

. [[l313]] Stone O.D. Long-Term Follow-up of Arthrodesis vs Total Joint Arthroplasty for Hallux Rigidus / O.D. Stone, R. Ray, C.E. Thomson [et al.] // Foot Ankle Int. – 2017. – Vol. 38, №4. – P. 375–380.

. [[l314]] Ariani A. The Italian Society for Rheumatology clinical practice guidelines for the diagnosis and management of knee, hip and hand osteoarthritis / A. Ariani, M. Manara, A. Fioravanti [et al.] // Reumatismo. – 2019. – Vol. 71, №S1. – P. 5–21.

. [[l315]] Rice D. Best Evidence Rehabilitation for Chronic Pain Part 5: Osteoarthritis / D. Rice, P. McNair, E. Huysmans, J. Letzen, P. Finan // J. Clin. Med. – 2019. – Vol. 8, №11. – Article ID 1769.

. [[l316]] Conley B. Core Recommendations for Osteoarthritis Care: A Systematic Review of Clinical Practice Guidelines / B. Conley, S. Bunzli, J. Bullen [et al.] // Arthritis Care Res. (Hoboken). – 2023. – Vol. 75, №9. – P. 1897–1907.

. [[l317]] Moseng T. EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis: 2023 update / T. Moseng, T. P. M. Vliet Vlieland, S. Battista [et al.] // Ann. Rheum. Dis. – 2024. – Vol. 83, №6. – P. 730–740.

. [[l318]] Kroon F.P. Self-management education programmes for osteoarthritis / F.P. Kroon, L.R. van der Burg, R. Buchbinder [et al.] // Cochrane Database Syst. Rev. – 2014. – Vol. 2014, №1. – Article ID CD008963.

. [[l319]] Hansson E.E. Effect of an education programme for patients with osteoarthritis in primary care – a randomized controlled trial / E.E. Hansson, M. Jönsson-Lundgren, A.M. Ronnheden [et al.] // BMC Musculoskelet. Disord. – 2010. – Vol. 11. – Article ID 244.

. [[l320]] Allen K.D. Telephone-based self-management of osteoarthritis: A randomized trial / K.D. Allen, E.Z. Oddone, C.J. Coffman [et al.] // Ann. Intern. Med. – 2010. – Vol. 153, №9. – P. 570–579.

. [[l321]] Panunzi S. Comparative efficacy of different weight loss treatments on knee osteoarthritis: A network meta-analysis / S. Panunzi, S. Maltese, A. De Gaetano [et al.] // Obes. Rev. – 2021. – Vol. 22, №8. – Article ID 13230.

. [[l322]] Chu I.J.H. Effects of meaningful weight loss beyond symptomatic relief in adults with knee osteoarthritis and obesity: a systematic review and meta-analysis / I.J.H. Chu, A.Y.T. Lim, C.L.W. Ng // Obes. Rev. – 2018. – Vol. 19, №11. – P. 1597–1607.

. [[l323]] Hall M. Diet-induced weight loss alone or combined with exercise in overweight or obese people with knee osteoarthritis: A systematic review and meta-analysis / M. Hall, B. Castelein, R. Wittoek [et al.] // Semin. Arthritis Rheum. – 2019. – Vol. 48, №5. – P. 765–777.

. [[l324]] Стребкова Е.А. Остеоартроз и ожирение / Е.А. Стребкова, Л.И. Алексеева // Научно-практическая ревматология. – 2015. – Т. 53, №5. – С. 542–552.

. [[l325]] Стребкова Е.А. Применение медикаментозной терапии ожирения в схеме лечения больных метаболическим фенотипом остеоартрита коленных суставов / Е.А. Стребкова, Л.И. Алексеева // Остеопороз и остеопатии. – 2020. – Т. 23, №2. – С. 167.

. [[l326]] Соловьева И.В. Влияние снижения массы тела на клинические проявления остеоартроза коленных суставов / И.В. Соловьева, Е.А. Стребкова, Л.И. Алексеева [и др.] // Ожирение и метаболизм. – 2014. – Т. 11, №4. – С. 41–47.

. [[l327]] Robson E.K. Effectiveness of Weight-Loss Interventions for Reducing Pain and Disability in People With Common Musculoskeletal Disorders: A Systematic Review With Meta-Analysis / E.K. Robson, R.K. Hodder, S.J. Kamper [et al.] // J. Orthop. Sports Phys. Ther. – 2020. – Vol. 50, №6. – P. 319–333.

. [[l328]] Salis Z. Weight loss is associated with reduced risk of knee and hip replacement: a survival analysis using Osteoarthritis Initiative data / Z. Salis, A. Sainsbury, H.I. Keen [et al.] // Int. J. Obes. (Lond). – 2022. – Vol. 46, №4. – P. 874–884.

. [[l329]] Salis Z. Association of Weight Loss and Weight Gain With Structural Defects and Pain in Hand Osteoarthritis: Data From the Osteoarthritis Initiative / Z. Salis, J. B. Driban, T. E. McAlindon [et al.] // Arthritis Care Res. (Hoboken). – 2024. – Vol. 76, №5. – P. 652–663.

. [[l330]] Butterworth P.A. The association between body mass index and musculoskeletal foot disorders: a systematic review / P.A. Butterworth, K.B. Landorf, S.E. Smith, H.B. Menz // Obes. Rev. – 2012. – Vol. 13, №7. – P. 630–642.

. [[l331]] Morley W.J. Simulated weight reduction using an anti-gravity treadmill – A pilot study of the impact of weight loss on foot and ankle arthritis / W.J. Morley, E. Dawe, R. Boyd [et al.] // Foot Ankle Surg. – 2021. – Vol. 27, №7. – P. 809–812.

. [[l332]] Gwinnutt J.M. Effects of diet on the outcomes of rheumatic and musculoskeletal diseases (RMDs): systematic review and meta-analyses informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs / J.M. Gwinnutt, M. Wieczorek, J. Rodríguez-Carrio [et al.] // RMD Open. – 2022. – Vol. 8, №2. – Article ID e002167.

. [[l333]] Лила А.М. Оценка влияния комбинации глюкозамина и хондроитина сульфата, дополненной нативным (неденатурированным) коллагеном II типа, экстрактом имбиря, витаминами группы В и аскорбиновой кислотой на клинические проявления ОА при различных фенотипах заболевания (предварительные результаты) / А.М. Лила, Л.И. Алексеева, Е.А. Таскина [и др.] // Современная ревматология. – 2024. – Т. 18, №6. – С. 124–127.

. [[l334]] Kou H. Effect of l-Carnitine Supplementation on Osteoarthritis: A Systematic Review / H. Kou, B. Li, Z. Wang, J. Ma // Mol. Nutr. Food Res. – 2024. – Vol. 68, №8. – Article ID 2300614.

. [[l335]] Fuggle N.R. Alternative and complementary therapies in osteoarthritis and cartilage repair / N.R. Fuggle, C. Cooper, R.O.C. Oreffo [et al.] // Aging Clin. Exp. Res. – 2020. – Vol. 32, №4. – P. 547–560.

. [[l336]] Vaishya, R. Current status of top 10 nutraceuticals used for Knee Osteoarthritis in India / R. Vaishya, A.K. Agarwal, A. Shah [et al.] // J. Clin. Orthop. Trauma. – 2018. – Vol. 9, №4. – P. 338–348.

. [[l337]] Yu G. Effectiveness of Boswellia and Boswellia extract for osteoarthritis patients: a systematic review and meta-analysis / G. Yu, W. Xiang, T. Zhang [et al.] // BMC Complement Med. Ther. – 2020. – Vol. 20, №1. – Article ID 225.

. [[l338]] Park J., Lee S.W. Medical treatment of osteoarthritis: botanical pharmacologic aspect / J. Park, S.W. Lee // J. Rheum. Dis. – 2024. – Vol. 31, №2. – P. 68–78.

. [[l339]] Алексеева Л.И. Эффективность и безопасность применения неденатурированного коллагена II типа у пациентов с остеоартритом коленных суставов: многоцентровое проспективное двойное слепое плацебо-контролируемое рандомизированное исследование / Л.И. Алексеева, Н.Г. Кашеварова, Е.А. Таскина [и др.] // Терапевтический архив. – 2024. – Т. 96, №5. – С. 500–509.

. [[l340]] Данилов А.Б. Новый фармаконутрицевтик Хондрогард®ТРИО для профилактики заболеваний опорно-двигательного аппарата и нутритивной поддержки пациентов с остеоартритом и неспецифической болью в спине: оценка клинических возможностей. Резолюция мультидисциплинарного экспертного совета / А.Б. Данилов, А.М. Лила, Ю.Н. Маджидова [и др.] // Неврология, нейропсихиатрия, психосоматика. – 2023. – Т. 15, №2. – С. 134–146.

. [[l341]] Алексеева Л.И., Шарапова Е.П. Применение препаратов АРТРА МСМ ФОРТЕ и АРТРА при остеоартрозе и болях в спине / Л.И. Алексеева, Е.П. Шарапова // Медицинский Совет. – 2017. – №10. – С. 96–101.

. [[l342]] Алексеева Л.И. Применение АРТРА MСM ФОРТЕ у пациентов с остеоартрозом коленного сустава: результаты рандомизированного открытого сравнительного изучения эффективности и переносимости препарата / Л.И. Алексеева, Е.П. Шарапова, Н.Г. Кашеварова [и др.] // Терапевтический архив. – 2015. – Т. 87, №12. – С. 370–376.

. [[l343]] Kitagawa T. Effectiveness of Rehabilitation for Osteoarthritis of the Knee: A Scoping Review of Network Meta-Analyses / T. Kitagawa, T. Denda, W. Okuyama [et al.] // Cureus. – 2024. – Vol. 16, №4. – Article ID 57661.

. [[l344]] Mo L. Exercise Therapy for Knee Osteoarthritis: A Systematic Review and Network Metaanalysis / L. Mo, B. Jiang, T. Mei [et al.] // Orthop. J. Sports Med. – 2023. – Vol. 11, №5. – Article ID 1172773.

. [[l345]] Karanasios S. Exercise-Based Interventions Are Effective in the Management of Patients with Thumb Carpometacarpal Osteoarthritis: A Systematic Review and Meta-Analysis of Randomised Controlled Trials / S. Karanasios, D. Mertyri, F. Karydis [et al.] // Healthcare (Basel). – 2024. – Vol. 12, №8. – Article ID 80823.

. [[l346]] Zhang Z.Y. Home-based vs center-based exercise on patient-reported and performancebased outcomes for knee osteoarthritis: a systematic review with meta-analysis / Z.Y. Zhang, L. Huang, L. Tian [et al.] // Front. Public Health. – 2024. – Vol. 12. – Article ID 1360824.

. [[l347]] Mao Y. Efficacy of home-based exercise in the treatment of pain and disability at the hip and knee in patients with osteoarthritis: a systematic review and meta-analysis / Y. Mao, B. Qiu, W. Wang [et al.] // BMC Musculoskelet. Disord. – 2024. – Vol. 25, №1. – Article ID 7585.

. [[l348]] Roddy E. Aerobic walking or strengthening exercise for osteoarthritis of the knee? A systematic review / E. Roddy, W. Zhang, M. Doherty // Ann. Rheum. Dis. – 2005. – Vol. 64, №4. – P. 544–548.

. [[l349]] Conn V.S. Physical activity interventions among adults with arthritis: meta-analysis of outcomes / V.S. Conn, A.R. Hafdahl, M.A. Minor [et al.] // Semin. Arthritis Rheum. – 2008. – Vol. 37, №5. – P. 307–316.

. [[l350]] Zhang W. OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines / W. Zhang, R.W. Moskowitz, G. Nuki [et al.] // Osteoarthritis Cartilage. – 2008. – Vol. 16, №2. – P. 137–162.

. [[l351]] Doi T. Effect of home exercise of quadriceps on knee osteoarthritis compared with nonsteroidal anti-inflammatory drugs: a randomized controlled trial / T. Doi, M. Akai, K. Fujino [et al.] // Am. J. Phys. Med. Rehabil. – 2008. – Vol. 87, №4. – P. 258–269.

. [[l352]] Hernández-Molina G. Effect of therapeutic exercise for hip osteoarthritis pain: results of a meta-analysis / G. Hernández-Molina, S. Reichenbach, Z. Bin [et al.] // Arthritis Rheum. – 2008. – Vol. 59, №9. – P. 1221–1228.

. [[l353]] O’Connor S.R. Walking exercise for chronic musculoskeletal pain: systematic review and meta-analysis / S.R. O’Connor, M.A. Tully, B. Ryan [et al.] // Arch. Phys. Med. Rehabil. – 2015. – Vol. 96, №4. – P. 724-734.

. [[l354]] Hurley M. Exercise interventions and patient beliefs for people with hip, knee or hip and knee osteoarthritis: a mixed methods review / M. Hurley, K. Dickson, R. Hallett [et al.] // Cochrane Database Syst. Rev. – 2018. – Vol. 4, №4. – Article ID CD010842.

. [[l355]] Goh S.L. Relative Efficacy of Different Exercises for Pain, Function, Performance and Quality of Life in Knee and Hip Osteoarthritis: Systematic Review and Network Meta-Analysis / S.L. Goh, M.S.M. Persson, J. Stocks [et al.] // Sports Med. – 2019. – Vol. 49, №5. – P. 743–761.

. [[l356]] Gwinnutt J.M. Effects of physical exercise and body weight on disease-specific outcomes of people with rheumatic and musculoskeletal diseases (RMDs): systematic reviews and metaanalyses informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs / J.M. Gwinnutt, M. Wieczorek, G. Cavalli [et al.] // RMD Open. – 2022. – Vol. 8, №1. – Article ID e002168.

. [[l357]] Lawford B.J. What should a toolkit to aid the delivery of therapeutic exercise for hip and knee osteoarthritis look like? Qualitative analysis of an international survey of 318 researchers, clinicians, and consumers by the OARSI Rehabilitation Discussion Group / B.J. Lawford, H. Master, J.B. Larsen [et al.] // Musculoskelet. Care. – 2023. – Vol. 21, №2. – P. 545–555.

. [[l358]] Xiang X.N. Telehealth-Supported Exercise or Physical Activity Programs for Knee Osteoarthritis: Systematic Review and Meta-Analysis / X.N. Xiang, Z.Z. Wang, J. Hu [et al.] // J. Med. Internet Res. – 2024. – Vol. 26. – Article ID 54876.

. [[l359]] Fenton S.A.M. Does the intensity of daily walking matter for protecting against the development of a slow gait speed in people with or at high risk of knee osteoarthritis? An observational study / S.A.M. Fenton, T. Neogi, D. Dunlop [et al.] // Osteoarthritis Cartilage. – 2018. – Vol. 26, №9. – P. 1181–1189.

. [[l360]] White D.K. Potential Functional Benefit From Light Intensity Physical Activity in Knee Osteoarthritis / D.K. White, J. Lee, J. Song [et al.] // Am. J. Prev. Med. – 2017. – Vol. 53, №5. – P. 689–696.

. [[l361]] White D.K. Daily walking and the risk of incident functional limitation in knee OA: An observational study / D.K. White, C. Tudor-Locke, Y. Zhang [et al.] // Arthritis Care Res. (Hoboken). – 2014. – Vol. 66, №9. – Article ID 22362.

. [[l362]] Qiu P. Causal effects of walking pace on osteoarthritis: a two-sample mendelian randomization study / P. Qiu, J. Wu, L. Kui [et al.] // Front. Genet. – 2023. – Vol. 14. – Article ID 1266158.

. [[l363]] Beck S. Unloader bracing in osteoarthritis of the knee - Is there a direct effect on the damaged cartilage? / S. Beck, F. Dittrich, A. Busch [et al.] // Knee. – 2023. – Vol. 40. – P. 16–23.

. [[l364]] Steingrebe H. Effects of Hip Bracing on Gait Biomechanics, Pain and Function in Subjects With Mild to Moderate Hip Osteoarthritis / H. Steingrebe, B.J. Stetter, S. Sell [et al.] // Front. Bioeng. Biotechnol. – 2022. – Vol. 10. – Article ID 888775.

. [[l365]] Fan Y. Valgus knee bracing may have no long-term effect on pain improvement and functional activity in patients with knee osteoarthritis: a meta-analysis of randomized trials / Y. Fan, Z. Li, H. Zhang [et al.] // J. Orthop. Surg. Res. – 2020. – Vol. 15, №1. – Article ID 13018.

. [[l366]] Marotta N. Comparative Effectiveness of Orthoses for Thumb Osteoarthritis: A Systematic Review and Network Meta-analysis / N. Marotta, A. Demeco, C. Marinaro [et al.] // Arch. Phys. Med. Rehabil. – 2021. – Vol. 102, №3. – P. 502–509.

. [[l367]] Stetter B.J. Impact of a Semi-Rigid Knee Orthotic Intervention on Pain, Physical Activity, and Functional Capacity in Patients with Medial Knee Osteoarthritis / B.J. Stetter, J. Fiedler, M. Arndt [et al.] // J. Clin. Med. – 2024. – Vol. 13, №6. – Article ID 1535.

. [[l368]] Berteau J.P. Knee Pain from Osteoarthritis: Pathogenesis, Risk Factors, and Recent Evidence on Physical Therapy Interventions / J.P. Berteau // J. Clin. Med. – 2022. – Vol. 11, №12. – Article ID 23252.

. [[l369]] Brouwer R.W. Brace treatment for osteoarthritis of the knee: a prospective randomized multi-centre trial / R.W. Brouwer, T.M. van Raaij, J.A.N. Verhaar [et al.] // Osteoarthritis Cartilage. – 2006. – Vol. 14, №8. – P. 777–783.

. [[l370]] Callaghan M.J. A randomised trial of a brace for patellofemoral osteoarthritis targeting knee pain and bone marrow lesions / M.J. Callaghan, M.J. Parkes, C.E. Hutchinson [et al.] // Ann. Rheum. Dis. – 2015. – Vol. 74, №6. – P. 1164–1170.

. [[l371]] Kirkley A. The effect of bracing on varus gonarthrosis / A. Kirkley, S. Webster-Bogaert, R. Litchfield [et al.] // J. Bone Joint Surg. Am. – 1999. – Vol. 81, №4. – P. 539–548.

. [[l372]] Van Raaij T.M. Medial knee osteoarthritis treated by insoles or braces: a randomized trial / T.M. Van Raaij, M. Reijman, R.W. Brouwer [et al.] // Clin. Orthop. Relat. Res. – 2010. – Vol. 468, №7. – P. 1926–1932.

. [[l373]] Zafar A.Q. The effectiveness of foot orthoses in the treatment of medial knee osteoarthritis: A systematic review / A.Q. Zafar, R. Zamani, M. Akrami // Gait Posture. – 2020. – Vol. 76. – P. 238–251.

. [[l374]] Nérot A. Clinical study on the unloading effect of hip bracing on gait in patients with hip osteoarthritis / A. Nérot, M. Nicholls // Prosthet. Orthot. Int. – 2017. – Vol. 41, №2. – P. 127–133.

. [[l375]] Menz H.B. Effectiveness of Foot Orthoses Versus Rocker-Sole Footwear for First Metatarsophalangeal Joint Osteoarthritis: Randomized Trial / H.B. Menz, M. Auhl, J.M. Tan [et al.] // Arthritis Care Res. – 2016. – Vol. 68, №5. – P. 581–589.

. [[l376]] Munteanu S.E. Shoe-stiffening inserts for first metatarsophalangeal joint osteoarthritis: a randomised trial / S.E. Munteanu, K.B. Landorf, J.A. McClelland [et al.] // Osteoarthr. Cartil. – 2021. – Vol. 29, №4. – P. 480–490.

. [[l377]] Paterson K.L. Foot orthoses for first metatarsophalangeal joint osteoarthritis: study protocol for the FORT randomised controlled trial / K.L. Paterson, R.S. Hinman, B.R. Metcalf [et al.] // BMC Musculoskelet. Disord. – 2020. – Vol. 21, №1. – P. 1–9.

. [[l378]] Reichenbach S. Effect of Biomechanical Footwear on Knee Pain in People With Knee Osteoarthritis: The BIOTOK Randomized Clinical Trial / S. Reichenbach, D.T. Felson, C.A. Hincapié [et al.] // JAMA. – 2020. – Vol. 323, №18. – P. 1802–1812.

. [[l379]] Ильченко Д.В. Комплексный подход к консервативному лечению пациентов с остеоартрозом первого плюснефалангового сустава / Д.В. Ильченко, Д.О. Ильин, А.А. Карданов [и др.] // Научно-практическая ревматология. – 2021. – Т. 59, №4. – С. 463–470.

. [[l380]] Welsh B.J. A case-series study to explore the efficacy of foot orthoses in treating first metatarsophalangeal joint pain / B.J. Welsh, A.C. Redmond, N. Chockalingam [et al.] // J. Foot Ankle Res. – 2010. – Vol. 3, №1.

. [[l381]] Duong V. Evaluation and Treatment of Knee Pain: A Review / V. Duong, W.M. Oo, C. Ding [et al.] // JAMA. – 2023. – Vol. 330, №16. – P. 1568–1580.

. [[l382]] Jindasakchai P. Therapeutic significance of insoles in patients with knee osteoarthritis / P. Jindasakchai, C. Angthong, P. Panyarachun [et al.] // Eur. Rev. Med. Pharmacol. Sci. – 2023. – Vol. 27, №11. – P. 5023–5030.

. [[l383]] Rillo O. PANLAR Consensus Recommendations for the Management in Osteoarthritis of Hand, Hip, and Knee / O. Rillo, H. Riera, C. Acosta [et al.] // J. Clin. Rheumatol. – 2016. – Vol. 22, №7. – P. 345–354.

. [[l384]] Hochberg M.C. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee / M.C. Hochberg, R.D. Altman, K.T. April [et al.] // Arthritis Care Res. – 2012. – Vol. 64, №4. – P. 465–474.

. [[l385]] Rayegani S.M. Safety and Effectiveness of Low-Level Laser Therapy in Patients With Knee Osteoarthritis: A Systematic Review and Meta-analysis / S.M. Rayegani, S.A. Raeissadat, S. Heidari [et al.] // J. Lasers Med. Sci. – 2017. – Vol. 8, №Suppl 1. – P. S12–S19.

. [[l386]] Li S. Electromagnetic fields for treating osteoarthritis / S. Li, B. Yu, D. Zhou [et al.] // Cochrane Database Syst. Rev. – 2013. – Vol. 2013, №12. – Article ID CD003523.

. [[l387]] We S.R. Effects of pulsed electromagnetic field on knee osteoarthritis: a systematic review / S.R. We, Y.H. Koog, K.I. Jeong [et al.] // Rheumatology. – 2013. – Vol. 52, №5. – P. 815–824.

. [[l388]] Li S. Efficacy Comparison of Five Different Acupuncture Methods on Pain, Stiffness, and Function in Osteoarthritis of the Knee: A Network Meta-Analysis / S. Li, P. Xie, Z. Liang [et al.] // Evid. Based Complement. Alternat. Med. – 2018. – Vol. – Article ID 1638904.

. [[l389]] Xu Q. The effectiveness of manual therapy for relieving pain, stiffness, and dysfunction in knee osteoarthritis: A systematic review and meta-analysis / Q. Xu, B. Chen, Y. Wang [et al.] // Pain Physician. – 2017. – Vol. 20, №4. – P. 229–243.

. [[l390]] Atamaz F.C. Comparison of the Efficacy of Transcutaneous Electrical Nerve Stimulation, Interferential Currents, and Shortwave Diathermy in Knee Osteoarthritis: A Double-Blind, Randomized, Controlled, Multicenter Study / F.C. Atamaz, B. Durmaz, M. Baydar [et al.] // Arch. Phys. Med. Rehabil. – 2012. – Vol. 93, №5. – P. 748–756.

. [[l391]] Fary R.E. The effectiveness of pulsed electrical stimulation in the management of osteoarthritis of the knee: results of a double-blind, randomized, placebo-controlled, repeatedmeasures trial / R.E. Fary, G.J. Carroll, T.G. Briffa [et al.] // Arthritis Rheum. – 2011. – Vol. 63, №5. – P. 1333–1342.

. [[l392]] Yang P.F. Efficacy of ultrasound in the treatment of osteoarthritis of the knee / P.F. Yang, D. Li, S.M. Zhang [et al.] // Orthop. Surg. – 2011. – Vol. 3, №3. – P. 181–187.

. [[l393]] Абрамович С.Г. Физиотерапия: национальное руководство / под ред. Г.Н. Пономаренко. - М.: ГЕОТАР-Медиа, 2009.

. [[l394]] Ушаков А.А. Практическая физиотерапия: Руководство для врачей / А.А. Ушаков. — М.: ООО «Издательство «Медицинское информационное агентство», 2013.

. [[l395]] Wuschech H. Effects of PEMF on patients with osteoarthritis: Results of a prospective, placebo-controlled, double-blind study / H. Wuschech, U. von Hehn, E. Mikus, R.H. Funk [et al.] // Bioelectromagnetics. – 2015. – Vol. 36, №8. – P. 576–585.

. [[l396]] Servodio Iammarrone C. Is there a role of pulsed electromagnetic fields in management of patellofemoral pain syndrome? Randomized controlled study at one year follow-up / C. Servodio Iammarrone, M. Cadossi, A. Sambri, E. Grosso, B. Corrado, F. Servodio Iammarrone [et al.] // Bioelectromagnetics. – 2016. – Vol. 37, №2. – P. 81–88.

. [[l397]] Abdel-aziem A.A. Effect of a physiotherapy rehabilitation program on knee osteoarthritis in patients with different pain intensities / A.A. Abdel-aziem, E.S. Soliman, D.M. Mosaad, A.H. Draz [et al.] // J Phys Ther Sci. – 2018. – Vol. 30, №2. – P. 307–312.

. [[l398]] Martin-Vega F.J. Phonophoresis through Nonsteroidal Anti-Inflammatory Drugs for Knee Osteoarthritis Treatment: Systematic Review and Meta-Analysis / F.J. Martin-Vega, D. Lucena-Anton, A. Galán-Mercant [et al.] // Biomedicines. – 2022. – Vol. 10, №12.

. [[l399]] Yang F.A. A systematic review and meta-analysis of the effect of phonophoresis on patients with knee osteoarthritis / F.A. Yang, H.L. Chen, C.W. Peng [et al.] // Sci. Rep. – 2022. – Vol. 12, №1. – Article ID 3254.

. [[l400]] Liu Y. Impact of soft tissue around the knee on the efficacy of extracorporeal shockwave therapy in knee osteoarthritis / Y. Liu, C. Wu, C. Chen [et al.] // Medicine (Baltimore). – 2022. – Vol. 101, №50. – Article ID e32334.

. [[l401]] Avendaño-Coy J. Extracorporeal shockwave therapy improves pain and function in subjects with knee osteoarthritis: A systematic review and meta-analysis of randomized clinical trials / J. Avendaño-Coy, N. Comino-Suárez, J. Grande-Muñoz [et al.] // Int. J. Surg. – 2020. – Vol. 82. – P. 64–75.

. [[l402]] Tsokanos A. The Efficacy of Manual Therapy in Patients with Knee Osteoarthritis: A Systematic Review / A. Tsokanos, E. Livieratou, E. Billis [et al.] // Medicina (Kaunas). – 2021. – Vol. 57, №7. – Article ID 0696.

. [[l403]] Feng T. Effectiveness and safety of manual therapy for knee osteoarthritis: An overview of systematic reviews and meta-analyses / T. Feng, X. Wang, Z. Jin [et al.] // Front. Public Health. – 2023. – Vol. 11. – Article ID 1081238.

. [[l404]] Wu Q. Efficacy of massage therapy in improving outcomes in knee osteoarthritis: A systematic review and meta-analysis / Q. Wu, J. Zhao, W. Guo [et al.] // Complement. Ther. Clin. Pract. – 2022. – Vol. 46. – Article ID 101522.

. [[l405]] Mohammedsadiq H.A. Effectiveness of home-based conventional exercise and cryotherapy on daily living activities in patients with knee osteoarthritis: A randomized controlled clinical trial / H.A. Mohammedsadiq, M.T. Rasool [et al.] // Medicine (Baltimore). – 2023. – Vol. 102, №18. – Article ID e33678.

. [[l406]] Madzia A. Sustained Acoustic Medicine Combined with A Diclofenac Ultrasound Coupling Patch for the Rapid Symptomatic Relief of Knee Osteoarthritis: Multi-Site Clinical Efficacy Study / A. Madzia, C. Agrawal, P. Jarit [et al.] // Open Orthop. J. – 2020. – Vol. 14, №1. – P. 176–l85.

. [[l407]] Valdes K. A systematic review of conservative interventions for osteoarthritis of the hand / K. Valdes, T. Marik [et al.] // J. Hand Ther. – 2010. – Vol. 23, №4. – P. 334–351.

. [[l408]] Beasley J. Conservative therapeutic interventions for osteoarthritic finger joints: A systematic review / J. Beasley, L.A. Ward, K. Knipper-Fisher [et al.] // J. Hand Ther. – 2019. – Vol. 32, №2. – P. 153-164.

. [[l409]] Ahern M. The effectiveness of physical therapies for patients with base of thumb osteoarthritis: Systematic review and meta-analysis / M. Ahern, J. Skyllas, A. Wajon, J. Hush [et al.] // Musculoskelet. Sci. Pract. – 2018. – Vol. 35. – P. 46–54.

. [[l410]] Flynn D.M. Chronic Musculoskeletal Pain: Nonpharmacologic, Noninvasive Treatments / D.M. Flynn [et al.] // Am. Fam. Physician. – 2020. – Vol. 102, №8. – P. 465–477.

. [[l411]] Andersen M.Ø. [Osteoarthritis of facet and sacroiliac joints] / M.Ø. Andersen, A.K. Holst, H.C. Horn [et al.] // Ugeskr. Laeger. – 2020. – Vol. 182, №42.

. [[l412]] Maicki T. PNF and manual therapy treatment results of patients with cervical spine osteoarthritis / T. Maicki, J. Bilski, E. Szczygiel, R. Trąbka [et al.] // J. Back Musculoskelet. Rehabil. – 2017. – Vol. 30, №5. – P. 1095–1101.

. [[l413]] Roddy E. Foot osteoarthritis: latest evidence and developments / E. Roddy, H.B. Menz [et al.] // Ther. Adv. Musculoskelet. Dis. – 2018. – Vol. 10, №4. – P. 91–103.

. [[l414]] Fernandes L. EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis / L. Fernandes, K.B. Hagen, J.W.J. Bijlsma [et al.] // Ann. Rheum. Dis. – 2013. – Vol. 72, №7. – P. 1125–1135.

. [[l415]] McAlindon T.E. OARSI guidelines for the non-surgical management of knee osteoarthritis / T.E. McAlindon, R.R. Bannuru, M.C. Sullivan [et al.] // Osteoarthritis Cartilage. – 2014. – Vol. 22, №3. – P. 363–388.

. [[l416]] Short-Term Effect of Kinesiotaping on Chronic Nonspecific Low Back Pain and Disability: A Meta-Analysis of Randomized Controlled Trials / S. Lin, B. Zhu, G. Huang [et al.] // Phys. Ther. – 2020. – Vol. 100, №2. – P. 238–254.

. [[l417]] Hartvigsen J. What low back pain is and why we need to pay attention / J. Hartvigsen, M.J. Hancock, A. Kongsted [et al.] // Lancet. – 2018. – Vol. 391, №10137. – P. 2356–2367.

. [[l418]] Pitsillides A. The effects of cognitive behavioural therapy delivered by physical therapists in knee osteoarthritis pain: A systematic review and meta-analysis of randomized controlled trials / A. Pitsillides, D. Stasinopoulos, K. Giannakou [et al.] // J. Bodyw. Mov. Ther. – 2021. – Vol. 25. – P. 157–164.

. [[l419]] Lin H.M. Impact of cognitive behavior therapy on osteoarthritis-associated pain, insomnia, depression, fatigue, and physical function in patients with knee/hip osteoarthritis: A systematic review and meta-analysis of randomized controlled trials / H.M. Lin, P.S. Hsieh, N.C. Chen [et al.] // Front. Med. (Lausanne). – 2023. – Vol. 9. – Article ID 1083095.

. [[l420]] Kamioka H. Overview of Systematic Reviews with Meta-Analysis Based on Randomized Controlled Trials of Balneotherapy and Spa Therapy from 2000 to 2019 / H. Kamioka, S. Nobuoka, J. Iiyama [et al.] // Int. J. Gen. Med. – 2020. – Vol. 13. – P. 429–442.

. [[l421]] Antonelli M. Effects of balneotherapy and spa therapy on quality of life of patients with knee osteoarthritis: a systematic review and meta-analysis / M. Antonelli, D. Donelli, A. Fioravanti [et al.] // Rheumatol. Int. – 2018. – Vol. 38, №10. – P. 1807–1824.

. [[l422]] Xiang J. Clinical Efficacy of Mudpack Therapy in Treating Knee Osteoarthritis: A MetaAnalysis of Randomized Controlled Studies / J. Xiang, D. Wu, J. Li [et al.] // Am. J. Phys. Med. Rehabil. – 2016. – Vol. 95, №2. – P. 121-131.

. [[l423]] Bartels E.M. Aquatic exercise for the treatment of knee and hip osteoarthritis / E.M. Bartels, C.B. Juhl, R. Christensen [et al.] // Cochrane Database Syst. Rev. – 2016. – Vol. 3, №3. – Article ID CD005523.

. [[l424]] Liu H. The effect of mud therapy on pain relief in patients with knee osteoarthritis: a metaanalysis of randomized controlled trials / H. Liu, C. Zeng, S. guang Gao [et al.] // J. Int. Med. Res. – 2013. – Vol. 41, №5. – P. 1418–1425.

. [[l425]] Verhagen A.P. Balneotherapy for osteoarthritis / A.P. Verhagen, S.M.A. Bierma-Zeinstra, M. Boers [et al.] // Cochrane Database Syst. Rev. – 2007. – №4. – Article ID CD006864.

. [[l426]] Maier G.S. Effectiveness of Mud-Pack Therapy and Mud-Bath Therapy in Osteoarthritis: A Systematic Review / G.S. Maier, G. Rosar, G. Dietz [et al.] // Complement. Med. Res. – 2024. – Vol. 31, №1. – P. 30–39.

. [[l427]] Zhu B. The effects of manual therapy in pain and safety of patients with knee osteoarthritis: a systematic review and meta-analysis / B. Zhu, H. Ba, L. Kong [et al.] // Syst. Rev. – 2024. – Vol. 13, №1. – Article ID 02467-7.

. [[l428]] Shepherd M.H. The influence of manual therapy dosing on outcomes in patients with hip osteoarthritis: a systematic review / M.H. Shepherd, J. Shumway, R.T. Salvatori [et al.] // J. Man. Manip. Ther. – 2022. – Vol. 30, №6. – P. 315–327.

. [[l429]] Sampath K.K. The effects of manual therapy or exercise therapy or both in people with hip osteoarthritis: a systematic review and meta-analysis / K.K. Sampath, R. Mani, T. Miyamori [et al.] // Clin. Rehabil. – 2016. – Vol. 30, №12. – P. 1141–1155.

. [[l430]] Xu J. Effectiveness and safety of massage for chronic pain in patients with knee osteoarthritis: A protocol for systematic review and meta-analysis / J. Xu, B. Wu, S. Xie [et al.] // Medicine (Baltimore). – 2022. – Vol. 101, №3. – Article ID E28533.

. [[l431]] Perlman A. Efficacy and Safety of Massage for Osteoarthritis of the Knee: a Randomized Clinical Trial / A. Perlman, S.G. Fogerite, O. Glass [et al.] // J. Gen. Intern. Med. – 2019. – Vol. 34, №3. – P. 379–386.

. [[l432]] Cui A. Weight change patterns across adulthood are associated with the risk of osteoarthritis: a population-based study / A. Cui, J. Zhang, H. Deng [et al.] // Aging Clin Exp Res. – 2024. – Vol. 36, №1. – Article ID 138.

. [[l433]] Nan K. Relationship of weight change patterns from young to middle adulthood with incident rheumatoid arthritis and osteoarthritis: a retrospective cohort study / K. Nan, M. Zhang, S. Hu [et al.] // Front Endocrinol (Lausanne). – 2024. – Vol. 14. – Article ID 1308254.

. [[l434]] Salis Z. Association of Decrease in Body Mass Index With Reduced Incidence and Progression of the Structural Defects of Knee Osteoarthritis: A Prospective Multi-Cohort Study / Z. Salis, B. Gallego, T.V. Nguyen [et al.] // Arthritis Rheumatol. – 2023. – Vol. 75, №4. – P. 533–543.

. [[l435]] Jiang L. Body mass index and hand osteoarthritis susceptibility: an updated meta-analysis / L. Jiang, X. Xie, Y. Wang [et al.] // Int J Rheum Dis. – 2016. – Vol. 19, №12. – P. 1244–1254.

. [[l436]] Reyes C. Association Between Overweight and Obesity and Risk of Clinically Diagnosed Knee, Hip, and Hand Osteoarthritis: A Population-Based Cohort Study / C. Reyes, K.M. Leyland, G. Peat [et al.] // Arthritis Rheumatol. – 2016. – Vol. 68, №8. – P. 1869–1875.

. [[l437]] Chen M. Life’s Essential 8 and its association with osteoarthritis and disability: a crosssectional study based on the NHANES 2005-2018 database / M. Chen, Y. Chen, C. Li // Qual Life Res. – 2024. – Vol. 33, №11. – P. 3141–3153.

. [[l438]] Li B. Exploration beyond osteoarthritis: the association and mechanism of its related comorbidities / B. Li, Z. Yang, Y. Li [et al.] // Front Endocrinol (Lausanne). – 2024. – Vol. 15. – Article ID 1352671.

. [[l439]] Dell’Isola A. Twenty-year trajectories of morbidity in individuals with and without osteoarthritis / A. Dell’Isola, F. Recenti, M. Englund [et al.] // RMD Open. – 2024. – Vol. 10, №2. – Article ID e004164.

. [[l440]] Sewell J. Association between arthritis and cardiovascular risk factors in community-based adults: an opportunity to target cardiovascular risk / J. Sewell, S.M. Hussain, Y. Wang [et al.] // BMC Cardiovasc Disord. – 2022. – Vol. 22, №1. – Article ID 2674.

. [[l441]] Runhaar J. The Challenges in the Primary Prevention of Osteoarthritis / J. Runhaar, S.M.A. Bierma-Zeinstra // Clin Geriatr Med. – 2022. – Vol. 38, №2. – P. 259–271.

. [[l442]] Grindstaff T.L. Neuromuscular Control Training Programs and Noncontact Anterior Cruciate Ligament Injury Rates in Female Athletes: A Numbers-Needed-to-Treat Analysis / T.L. Grindstaff, R.R. Hammill, A.E. Tuzson [et al.] // J Athl Train. – 2006. – Vol. 41, №4. – P. 450456.

. [[l443]] Whittaker J.L. OPTIKNEE 2022: consensus recommendations to optimise knee health after traumatic knee injury to prevent osteoarthritis / J.L. Whittaker, A.G. Culvenor, C.B. Juhl [et al.] // Br J Sports Med. – 2022. – Vol. 56, №24. – P. 1393–1405.

. [[l444]] Whittaker J.L. A lifespan approach to osteoarthritis prevention / J.L. Whittaker, J. Runhaar, S. Bierma-Zeinstra [et al.] // Osteoarthritis Cartilage. – 2021. – Vol. 29, №12. – P. 1638–1653.

. [[l445]] de Melo L.R. National Osteoarthritis Strategy brief report: Prevention of osteoarthritis / L.R. de Melo, D. Hunter, L. Fortington [et al.] // Aust J Gen Pract. – 2020. – Vol. 49, №5. – P. 273–275.

. [[l446]] Gwinnutt J.M. 2021 EULAR recommendations regarding lifestyle behaviours and work participation to prevent progression of rheumatic and musculoskeletal diseases / J.M. Gwinnutt, M. Wieczorek, A. Balanescu [et al.] // Ann Rheum Dis. – 2023. – Vol. 82, №1. – P. 48–56.

. [[l447]] Emery C.A. OARSI Clinical Trials Recommendations: Design and conduct of clinical trials for primary prevention of osteoarthritis by joint injury prevention in sport and recreation / C.A. Emery, E.M. Roos, E. Verhagen [et al.] // Osteoarthritis Cartilage. – 2015. – Vol. 23, №5. – P. 815–825.

. [[l448]] Ratzlaff C.R. New developments in osteoarthritis. Prevention of injury-related knee osteoarthritis: opportunities for the primary and secondary prevention of knee osteoarthritis / C.R. Ratzlaff, M.H. Liang // Arthritis Res Ther. – 2010. – Vol. 12, №4. – Article ID AR3113.

. [[l449]] Whittaker J.L. Risk factors for knee osteoarthritis after traumatic knee injury: a systematic review and meta-analysis of randomised controlled trials and cohort studies for the OPTIKNEE Consensus / J.L. Whittaker, J.M. Losciale, C.B. Juhl [et al.] // Br J Sports Med. – 2022. – Vol. 56, №24. – P. 1406–1421.

. [[l450]] Jones R.K. A new approach to prevention of knee osteoarthritis: reducing medial load in the contralateral knee / R.K. Jones, G.J. Chapman, A.H. Findlow [et al.] // J Rheumatol. – 2013. – Vol. 40, №3. – P. 309–315.

. [[l451]] Hutchison L. Relationship Between Knee Biomechanics and Pain in People With Knee Osteoarthritis: A Systematic Review and Meta-Analysis / L. Hutchison, J. Grayson, C. Hiller [et al.] // Arthritis Care Res (Hoboken). – 2023. – Vol. 75, №6. – P. 1351–1361.

. [[l452]] Halstead J. Current and future advances in practice: mechanical foot pain / J. Halstead, S.E. Munteanu // Rheumatol Adv Pract. – 2023. – Vol. 7, №3. – Article ID RKAD081.

. [[l453]] Russell E.M. Lateral wedges alter mediolateral load distributions at the knee joint in obese individuals / E.M. Russell, R.H. Miller, B.R. Umberger [et al.] // J Orthop Res. – 2013. – Vol. 31, №5. – P. 665–671.

. [[l454]] Kemker B.P. Hip and Knee Bracing: Categorization, Treatment Algorithm, and Systematic Review / B.P. Kemker, R. Kankaria, N. Patel [et al.] // J Am Acad Orthop Surg Glob Res Rev. – 2021. – Vol. 5, №6. – Article ID JAAOSGLOBAL-D-20-00181.

. [[l455]] Lohmander L.S. Incidence of severe knee and hip osteoarthritis in relation to different measures of body mass: a population-based prospective cohort study / L.S. Lohmander, M.G. De Verdier, J. Rollof [et al.] // Ann Rheum Dis. – 2009. – Vol. 68, №4. – P. 490–496.

. [[l456]] Golightly Y.M. Foot disorders associated with overpronated and oversupinated foot function: the Johnston County osteoarthritis project / Y.M. Golightly, M.T. Hannan, A.B. Dufour [et al.] // Foot Ankle Int. – 2014. – Vol. 35, №11. – P. 1159–1165.

. [[l457]] Mahiquez M.Y. Positive hindfoot valgus and osteoarthritis of the first metatarsophalangeal joint / M.Y. Mahiquez, F.V. Wilder, H.M. Stephens // Foot Ankle Int. – 2006. – Vol. 27, №12. – P. 1055–1059.

. [[l458]] Li Z. Passive stiffness of the quadriceps predicts the incidence of clinical knee osteoarthritis in twelve months / Z. Li, K.L. Leung, C. Huang [et al.] // Eur J Phys Rehabil Med. – 2023. – Vol. 59, №1. – P. 65–74.

. [[l459]] Slemenda C. Reduced quadriceps strength relative to body weight: a risk factor for knee osteoarthritis in women? / C. Slemenda, D.K. Heilman, K.D. Brandt [et al.] // Arthritis Rheum. – 1998. – Vol. 41, №11. – P. 1951–1959.

. [[l460]] Patterson B.E. Muscle strength and osteoarthritis of the knee: a systematic review and meta-analysis of longitudinal studies / B.E. Patterson, M.A. Girdwood, T.J. West [et al.] // Skeletal Radiol. – 2023. – Vol. 52, №11. – P. 2085–2097.

. [[l461]] Culvenor A.G. Knee extensor strength and risk of structural, symptomatic, and functional decline in knee osteoarthritis: a systematic review and meta-analysis / A.G. Culvenor, A. Ruhdorfer, C. Juhl [et al.] // Arthritis Care Res (Hoboken). – 2017. – Vol. 69, №5. – P. 649–658.

. [[l462]] Hulshof C.T.J. The effect of occupational exposure to ergonomic risk factors on osteoarthritis of hip or knee and selected other musculoskeletal diseases: a systematic review and meta-analysis from the WHO/ILO Joint Estimates of the Work-related Burden of Disease and Injury / C.T.J. Hulshof, F. Pega, S. Neupane [et al.] // Environ Int. – 2021. – Vol. 150. – Article ID 106349.

. [[l463]] Unverzagt S. Physically demanding occupations among females and sex-related differences to develop osteoarthritis of the hip: a systematic review and meta-analysis / S. Unverzagt, A. Bergmann, K. Denny [et al.] // J Occup Med Toxicol. – 2024. – Vol. 19, №1. – Article ID 6.

. [[l464]] Bergmann A. Occupational strain as a risk for hip osteoarthritis / A. Bergmann, U. Bolm-Audorff, D. Krone [et al.] // Dtsch Arztebl Int. – 2017. – Vol. 114, №35–36. – P. 581–588.

. [[l465]] Solovieva S. Occupation, Physical Workload Factors, and Disability Retirement as a Result of Hip Osteoarthritis in Finland, 2005-2013 / S. Solovieva, T. Kontio, E. Viikari-Juntura [et al.] // J Rheumatol. – 2018. – Vol. 45, №4. – P. 555–562.

. [[l466]] Seidler A. Dose-response relationship between cumulative physical workload and osteoarthritis of the hip – a meta-analysis applying an external reference population for exposure assignment / A. Seidler, L. Lüben, J. Hegewald [et al.] // BMC Musculoskelet Disord. – 2018. – Vol. 19, №1. – Article ID 182.

. [[l467]] Jensen L.K. Hip osteoarthritis: influence of work with heavy lifting, climbing stairs or ladders, or combining kneeling/squatting with heavy lifting / L.K. Jensen // Occup Environ Med. – 2008. – Vol. 65, №1. – P. 6–19.

. [[l468]] Jensen L.K. Knee osteoarthritis: influence of work involving heavy lifting, kneeling, climbing stairs or ladders, or kneeling/squatting combined with heavy lifting / L.K. Jensen // Occup Environ Med. – 2008. – Vol. 65, №2. – P. 72–89.

. [[l469]] Vignon É. Osteoarthritis of the knee and hip and activity: a systematic international review and synthesis (OASIS) / É. Vignon, J.P. Valat, M. Rossignol [et al.] // Joint Bone Spine. – 2006. – Vol. 73, №4. – P. 442–455.

. [[l470]] Unverzagt S. Influence of physically demanding occupations on the development of osteoarthritis of the hip: a systematic review / S. Unverzagt, U. Bolm-Audorff, T. Frese [et al.] // J Occup Med Toxicol. – 2022. – Vol. 17, №1. – Article ID 18.

. [[l471]] Schram B. Risk factors for development of lower limb osteoarthritis in physically demanding occupations: a narrative umbrella review / B. Schram, R. Orr, R. Pope [et al.] // J Occup Health. – 2020. – Vol. 62, №1. – Article ID e12103.

. [[l472]] Wang X. Occupational Risk in Knee Osteoarthritis: A Systematic Review and MetaAnalysis of Observational Studies / X. Wang, T.A. Perry, N. Arden [et al.] // Arthritis Care Res (Hoboken). – 2020. – Vol. 72, №9. – P. 1213–1223.

. [[l473]] Nonnenmann M.W. Dairy farm worker exposure to awkward knee posture during milking and feeding tasks / M.W. Nonnenmann, D.C. Anton, F. Gerr [et al.] // J Occup Environ Hyg. – 2010. – Vol. 7, №8. – P. 483–489.

. [[l474]] Plotz B. Current Epidemiology and Risk Factors for the Development of Hand Osteoarthritis / B. Plotz, F. Bomfim, M.A. Sohail [et al.] // Curr Rheumatol Rep. – 2021. – Vol. 23, №8. – Article ID 61.

. [[l475]] Jensen V. Occupational use of precision grip and forceful gripping, and arthrosis of finger joints: a literature review / V. Jensen, H. Bøggild, J.P. Johansen // Occup Med (Oxford). – 1999. – Vol. 49, №6. – P. 383–388.

. [[l476]] Hammer P.E.C. Associations of work activities requiring pinch or hand grip or exposure to hand-arm vibration with finger and wrist osteoarthritis: a meta-analysis / P.E.C. Hammer, R. Shiri, A.I. Kryger [et al.] // Scand J Work Environ Health. – 2014. – Vol. 40, №2. – P. 133–145.

. [[l477]] Teichtahl A.J. Occupational risk factors for hip osteoarthritis are associated with early hip structural abnormalities: a 3.0 T magnetic resonance imaging study of community-based adults / A.J. Teichtahl, S. Smith, Y. Wang [et al.] // Arthritis Res Ther. – 2015. – Vol. 17, №1. – Article ID 19.

. [[l478]] Российская ассоциация эндокринологов, Ассоциация ревматологов России, Российская ассоциация травматологов-ортопедов, Российская ассоциация гинекологовэндокринологов, Российская ассоциация по остеопорозу. Остеопороз: клинические рекомендации [Электронный ресурс]. – 2021. – URL: https://cr.minzdrav.gov.ru/view-cr/87_4 (дата обращения: 03.03.2025).

. [[l479]] Geusens P.P. Osteoporosis and osteoarthritis: shared mechanisms and epidemiology / P.P. Geusens, J.P. Van Den Bergh // Current Opin Rheumatol. – 2016. – Vol. 28, №2. – P. 97–103.

. [[l480]] Qu Y. Osteoporosis and osteoarthritis: a bi-directional Mendelian randomization study / Y. Qu, S. Chen, M. Han [et al.] // Arthritis Res Ther. – 2023. – Vol. 25, №1. – Article ID 242.

. [[l481]] Алексеева Л.И. Оценка эффективности и переносимости ибандроновой кислоты у больных с сочетанием остеоартроза коленных суставов и остеопороза: пилотное исследование / Л.И. Алексеева, Е.М. Зайцева, Е.П. Шарапова [и др.] // Терапевтический архив. – 2013. – Т. 85, №5. – С. 30–36.

. [[l482]] Sethi V. Clinical Assessment of Osteoarthritis Pain: Contemporary Scenario, Challenges, and Future Perspectives / V. Sethi, C. Anand, O. Della Pasqua [et al.] // Pain Ther. – 2024. – Vol. 13, №3. – P. 391–408.

. [[l483]] Zolio L. Systematic review and meta-analysis of the prevalence of neuropathic-like pain and/or pain sensitization in people with knee and hip osteoarthritis / L. Zolio, K.Y. Lim, J.E. McKenzie [et al.] // Osteoarthritis Cartilage. – 2021. – Vol. 29, №8. – P. 1096–1116.

. [[l484]] Favero M. Assessment of Neuropathic Pain in Erosive Hand Osteoarthritis / M. Favero, M. Cacciavillani, F. Ometto [et al.] // J Clin Med. – 2024. – Vol. 13, №11. – Article ID 3244.

. [[l485]] Steen Pettersen P. Peripheral and Central Sensitization of Pain in Individuals With Hand Osteoarthritis and Associations With Self-Reported Pain Severity / P. Steen Pettersen, T. Neogi, K. Magnusson [et al.] // Arthritis Rheumatol. – 2019. – Vol. 71, №7. – P. 1070–1077.

. [[l486]] Price D.D. The validation of visual analogue scales as ratio scale measures for chronic and experimental pain / D.D. Price, P.A. McGrath, A. Rafii [et al.] // Pain. – 1983. – Vol. 17, №1. – P. 45–56.

. [[l487]] Bijur P.E. Validation of a verbally administered numerical rating scale of acute pain for use in the emergency department / P.E. Bijur, C.T. Latimer, E.J. Gallagher [et al.] // Acad Emerg Med. – 2003. – Vol. 10, №4. – P. 390–392.

. [[l488]] Williamson A. Pain: a review of three commonly used pain rating scales / A. Williamson, B. Hoggart // J Clin Nurs. – 2005. – Vol. 14, №7. – P. 798–804.

. [[l489]] Алексеев В.В. Боль: руководство для врачей и студентов / под ред. Н.Н. Яхно. – М. : МЕДпресс-информ, 2009.

. [[l490]] Bellamy N.B.W. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee / N.B.W. Bellamy // J Rheumatol. – 1988. – P. 1833–1840.

. [[l491]] Bellamy N. The WOMAC Knee and Hip Osteoarthritis Indices: development, validation, globalization and influence on the development of the AUSCAN Hand Osteoarthritis Indices / N. Bellamy // Clin Exp Rheumatol. – 2005. – Vol. 23, №5 Suppl 39. – С. S148–S153.

. [[l492]] Roos E.M. Knee Injury and Osteoarthritis Outcome Score (KOOS) — development of a self-administered outcome measure / E.M. Roos, H.P. Roos, L.S. Lohmander [et al.] // J Orthop Sports Phys Ther. – 1998. – Vol. 28, №2. – P. 88–96.

. [[l493]] Бараненков А.А. Региональная адаптация шкалы оценки исходов повреждений и заболеваний коленного сустава KOOS / А.А. Бараненков, О.М. Голозубов, В.Г. Голубев, Г.Ш. Голубев [и др.] // Травматология и ортопедия России. – 2007. – Т. 1, №43. – С. 26–32.

. [[l494]] Nilsdotter A.K. Hip disability and osteoarthritis outcome score (HOOS) – Validity and responsiveness in total hip replacement / A.K. Nilsdotter, L.S. Lohmander, M. Klässbo [et al.] // BMC Musculoskelet Disord. – 2003. – Vol. 4, №1. – P. 1–8.

. [[l495]] Klässbo M. Hip disability and osteoarthritis outcome score. An extension of the Western Ontario and McMaster Universities Osteoarthritis Index / M. Klässbo, E. Larsson, E. Mannevik [et al.] // Scand J Rheumatol. – 2003. – Vol. 32, №1. – P. 46–51.

. [[l496]] de Groot I.B. Validation of the Dutch version of the Hip disability and Osteoarthritis Outcome Score / I.B. de Groot, M. Reijman, C.B. Terwee [et al.] // Osteoarthritis Cartilage. – 2009. – Vol. 17, №1. – P. 132–138.

. [[l497]] Thorborg K. Validity, reliability and responsiveness of patient-reported outcome questionnaires when assessing hip and groin disability: a systematic review / K. Thorborg, E.M. Roos, E.M. Bartels [et al.] // Br J Sports Med. – 2010. – Vol. 44, №16. – P. 1186–1196.

. [[l498]] Dayton M.R. Performance-based versus self-reported outcomes using the HOOS following total hip arthroplasty / M.R. Dayton, D.L. Judd, C.A. Hogan [et al.] // Am J Phys Med Rehabil. – 2016. – Vol. 95, №2. – Article ID 132.

. [[l499]] Bellamy N. Population-based normative values for the Australian/Canadian (AUSCAN) Hand Osteoarthritis Index: part 2 / N. Bellamy, C. Wilson, J. Hendrikz [et al.] // Semin Arthritis Rheum. – 2011. – Vol. 41, №2. – P. 149–156.

. [[l500]] Allen K.D. Validity, factor structure, and clinical relevance of the AUSCAN Osteoarthritis Hand Index / K.D. Allen, J.M. Jordan, J.B. Renner [et al.] // Arthritis Rheum. – 2006. – Vol. 54, №2. – P. 551–556.

. [[l501]] Bellamy N. Dimensionality and clinical importance of pain and disability in hand osteoarthritis: Development of the Australian/Canadian (AUSCAN) osteoarthritis hand index / N. Bellamy, J. Campbell, B. Haraoui [et al.] // Osteoarthritis Cartilage. – 2002. – Vol. 10, №11. – P. 855–862.

. [[l502]] Bellamy N. Recommendations for a core set of outcome measures for future phase III clinical trials in knee, hip, and hand osteoarthritis: Consensus development at OMERACT III / N. Bellamy, J. Kirwan [et al.] // J Rheumatol. – 1997. – P. 799–802.

. [[l503]] Dreiser R.L. Validation of an algofunctional index for osteoarthritis of the hand / R.L. Dreiser // Rev Rhum Engl Ed. – 1995. – Vol. 62, №6. – P. 43–53.

. [[l504]] Fairbank J.C.T. The Oswestry low back pain disability questionnaire / J.C.T. Fairbank, J.B. Davies, J. Couper [et al.] // Physiotherapy. – 1980. – Vol. 66, №8. – P. 271–273.

. [[l505]] Бахтадзе М.А. Индекс ограничения жизнедеятельности из-за боли в нижней части спины (опросник Освестри): оценка надёжности и валидности русской версии / М.А. Бахтадзе, Д.А. Болотов, К.О. Кузьминов [и др.] // Мануальная терапия. – 2016. – №4(64). – С. 93–98.

. [[l506]] Черепанов Е.А. Русская версия опросника Освестри: культурная адаптация и валидность / Е.А. Черепанов // Хирургия позвоночника. – 2009. – №3. – С. 93–98.

. [[l507]] Bouhassira D. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4) / D. Bouhassira, N. Attal, H. Alchaar [et al.] // Pain. – 2005. – Vol. 114, №1–2. – P. 29–36.

. [[l508]] Bouhassira D. Prevalence of chronic pain with neuropathic characteristics in the general population / D. Bouhassira, M. Lantéri-Minet, N. Attal [et al.] // Pain. – 2008. – Vol. 136, №3. – P. 380–387.

. [[l509]] Freynhagen R. painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain / R. Freynhagen, R. Baron, U. Gockel [et al.] // Curr Med Res Opin. – 2006. – Vol. 22, №10. – P. 1911–1920.

. [[l510]] Петрова М.М. Диагностика нейропатической боли: шкалы и вопросники / М.М. Петрова, Н.А. Шнайдер, Е.А. Пронина [и др.] // Сибирское медицинское обозрение. – 2020. – №3. – С. 61–69.

. [[l511]] Общероссийская общественная организация «Российская ассоциация геронтологов и гериатров». Хроническая боль у пациентов пожилого и старческого возраста [Электронный ресурс]. – 2020. – URL: https://static/0.minzdrav.gov.ru/system/attachments/attaches/000/054/894/original/Клинические_рекомендации_Хроническая_боль.pdf (дата обращения: 06.03.2025).

. [[l512]] Laires P. Inadequate Pain Relief Among Patients With Primary Knee Osteoarthritis - Analysis From The Portuguese Sample Of The Survey Of Osteoarthritis Real World Therapies (SORT) / P. Laires, J. Laíns, L. Miranda [et al.] // Value Health. – 2014. – Vol. 17, №7. – Article ID A386.

. [[l513]] Herrero-Beaumont G. Systemic osteoarthritis: the difficulty of categorically naming a continuous condition / G. Herrero-Beaumont, F. Castro-Dominguez, A. Migliore [et al.] // Aging Clin Exp Res. – 2024. – Vol. 36, №1. – Article ID 45.

. [[l514]] Collins N.J. Measures of knee function: International Knee Documentation Committee (IKDC) Subjective Knee Evaluation Form, Knee Injury and Osteoarthritis Outcome Score (KOOS), Knee Injury and Osteoarthritis Outcome Score Physical Function Short Form (KOOSPS), Knee Outcome Survey Activities of Daily Living Scale (KOS-ADL), Lysholm Knee Scoring Scale, Oxford Knee Score (OKS), Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), Activity Rating Scale (ARS), and Tegner Activity Score (TAS) / N.J. Collins, D. Misra, D.T. Felson [et al.] // Arthritis Care Res. (Hoboken). – 2011. – Vol. 63, Suppl. 11. – P. S208–S228.
